UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14F-1
INFORMATION STATEMENT PURSUANT
TO
SECTION 14(F) OF THE SECURITIES
EXCHANGE ACT OF 1934
AND RULE 14F-1
THEREUNDER
(Exact name of registrant as
specified in its charter)
0-6516
(Commission File
Number)
|
|
|
Delaware
(State or other
jurisdiction
of incorporation)
|
|
13-2529596
(IRS Employer
Identification No.)
|
14 Philips Parkway
Montvale, New Jersey 07645-9998
(Address of principal executive
offices and zip code)
(201) 391-8100
(Registrants telephone
number, including area code):
TABLE OF CONTENTS
DATASCOPE
CORP.
14 Philips Parkway
Montvale, New Jersey 07645
(201) 391-8100
INFORMATION
STATEMENT PURSUANT TO SECTION 14(F) OF
THE SECURITIES EXCHANGE ACT OF 1934 AND
RULE 14F-1
THEREUNDER
This Information Statement is being mailed on or about
October 24, 2008, as part of the
Solicitation/Recommendation Statement on
Schedule 14D-9
(the
Schedule 14D-9
)
of Datascope Corp. (
Datascope
or the
Company
) to the holders of record of shares
of common stock of Datascope (the
Common
Stock
). You are receiving this Information Statement
in connection with the possible election of persons designated
by Getinge AB, a Swedish aktiebolag (
Parent
),
to a majority of the seats on the Board of Directors of
Datascope (the
Datascope Board
).
On September 15, 2008, Datascope entered into an Agreement
and Plan of Merger (the
Merger Agreement
)
with Parent and DaVinci Merger Sub, Inc., a Delaware corporation
(
Purchaser
) and a
wholly-owned,
indirect subsidiary of Parent. Pursuant to the Merger Agreement,
subject to certain conditions and as more fully described in the
Merger Agreement, (1) Parent will cause Purchaser to
commence a cash tender offer (the
Offer
) for
all outstanding shares of Common Stock at a price of $53.00 per
share, net to the seller in cash, without interest and less any
applicable withholding taxes (or such other amount per share as
may be paid pursuant to the Offer) (the
Offer
Price
), and (2) Purchaser will be merged with and
into Datascope (the
Merger
). If the Offer and
the Merger are completed, Datascope will become a wholly-owned,
indirect subsidiary of Parent.
The Merger Agreement provides that, promptly upon the close of
the Offer, and from time to time thereafter, Purchaser will be
entitled to designate directors (referred to as
Purchasers Designees
) on the Datascope
Board that will give Purchaser board representation that is at
least proportionate to its ownership interest. The Merger
Agreement requires that Datascope promptly take necessary action
to cause Purchasers Designees to be elected or appointed
to the Datascope Board under the circumstances described in the
Merger Agreement. This Information Statement is required by
Section 14(f) of the Securities Exchange Act of 1934, as
amended (the
Exchange Act
), and
Rule 14f-1
thereunder.
You are urged to read this Information Statement carefully. You
are not, however, required to take any action in connection with
this Information Statement.
The information contained in this Information Statement
concerning Parent and Purchaser and Purchasers Designees
has been furnished to us by Parent and Purchaser. Datascope
assumes no responsibility for the accuracy or completeness of
such information.
RIGHT
TO DESIGNATE DIRECTORS; PARENTS DESIGNEES
The Merger Agreement provides that, promptly after Purchaser
accepts for payment and pays for any shares of Common Stock
tendered and not withdrawn pursuant to the Offer (the
Appointment Time
), and at all times
thereafter, Purchaser shall be entitled to elect or designate
such number of directors, rounded up to the next whole number,
on the Datascope Board as is equal to the product of the total
number of directors on the Datascope Board (giving effect to the
directors elected or designated by Purchaser pursuant to this
sentence) multiplied by the percentage that the aggregate number
of shares of the Common Stock beneficially owned by Parent,
Purchaser or any of its affiliates bears to the total number of
shares of the Common Stock then outstanding, such directors to
be split up among the three classes of the Datascope Board so as
to keep the classes approximately even in the number of
directors. The Merger Agreement further provides that Datascope
will, upon request by Purchaser at any time following the
purchase of and payment for shares of the Common Stock pursuant
to the Offer, take such actions, including, but not limited to
(a) promptly filling vacancies or newly created
directorships on the Datascope Board, (b) promptly
increasing the size of the Datascope Board (including by
amending the bylaws of Datascope if necessary so as to increase
the size of
the Datascope Board)
and/or
(c) promptly securing the resignations of such number of
incumbent directors as are necessary or desirable to enable
Purchasers Designees to be so elected or designated to the
Datascope Board, and shall use reasonable best efforts to cause
Purchasers Designees to be so elected or designated at
such time.
The Merger Agreement also provides that, upon Purchasers
request following the Appointment Time, Datascope shall also
cause persons elected or designated by Purchaser to constitute
the same percentage (rounded up to the next whole number) as is
on the Datascope Board of (i) each committee of the
Datascope Board, (ii) each board of directors (or similar
body) of each of Datascopes subsidiaries and
(iii) each committee (or similar body) of such board, in
each case to the extent permitted by applicable law and the
NASDAQ Marketplace Rules.
Purchaser will select its designees from among its directors and
executive officers listed on Schedule A to this Information
Statement. If additional designees are required in order to
constitute a majority of the Datascope Board, such additional
designees will be selected by Purchaser from among the directors
and executive officers of Parent contained in Schedule I to
the Offer to Purchase, dated September 30, 2008 (as amended
or supplemented from time to time, the
Offer to
Purchase
), of Purchaser and Parent, which was filed
with the Securities and Exchange Commission (the
SEC
) as Exhibit 99.(A)(1)(A) to
Purchasers and Parents tender offer statement on
Schedule TO, which schedule is incorporated by reference
herein.
None of the persons from among whom Purchasers Designees
will be selected, or their associates, is a director of, or
holds any management or other employment position with,
Datascope. To our knowledge, except as set forth in
Schedule A annexed hereto, none of the persons from among
whom Purchasers Designees will be selected or their
associates beneficially owns any equity securities, or rights to
acquire any equity securities, of Datascope or has been involved
in any transactions with Datascope or any of its directors or
executive officers that are required to be disclosed pursuant to
the rules and regulations of the SEC.
CERTAIN
INFORMATION REGARDING DATASCOPE
The Common Stock is the only class of voting securities of
Datascope currently outstanding. Each share of Common Stock has
one vote. As of the close of business on September 12,
2008, there were 15,873,152 shares of Common Stock issued
and outstanding (which does not include deferred share units
held by current or former Datascope directors).
DIRECTORS
OF DATASCOPE
Set forth below are the name, age and position of each director
of Datascope as of September 12, 2008.
|
|
|
|
|
|
|
Name
|
|
Age
|
|
|
Principal Occupation or Employment
|
|
Alan B. Abramson(1)
|
|
|
62
|
|
|
Attorney and President of Abramson Brothers, Inc.
|
David Altschiller(2)
|
|
|
67
|
|
|
Chief Executive Officer of Altschiller Assoc., LLC.
|
David R. Dantzker, M.D.(3)
|
|
|
65
|
|
|
Partner of Wheatley Partners, L.P.
|
Robert E. Klatell(4)
|
|
|
62
|
|
|
Director
|
James. J. Loughlin(5)
|
|
|
65
|
|
|
Director
|
Lawrence Saper
|
|
|
80
|
|
|
Chairman of the Board and CEO of Datascope Corp.
|
William W. Wyman(6)
|
|
|
70
|
|
|
Independent Management Consultant
|
|
|
|
(1)
|
|
Mr. Abramson has served as President of Abramson Brothers,
Inc. since 1972.
|
|
(2)
|
|
Mr. Altschiller has served as a consultant to the Company
since 1998. Mr. Altschiller ran various advertising
agencies as Chief Creative Officer, Chairman and CEO, including
Altschiller, Reitzfeld, Inc., Altschiller & Co, and
Hill Holliday/Altschiller. Since January 2001,
Mr. Altschiller has been the Chief Executive Officer of
Altschiller Assoc., LLC.
|
2
|
|
|
(3)
|
|
Dr. Dantzker has served as a partner at Wheatley Partners,
L.P., a New York-based venture capital firm, since January 2001.
Prior to serving with Wheatley, Dr. Dantzker served as
Chief Executive Officer of Redox Pharmaceuticals Corporation
from November 2000 until October 2001. Dr. Dantzker served
as President of Long Island Jewish Medical Center from July 1993
to October 1997 and President of North Shore LIJ
Health System from October 1997 until May 2000.
Dr. Dantzker was chairman of the board of directors of
Versamed, Inc., a private medical supply company and is
presently chairman of Oligomerix, a private biopharmaceutical
company. He is also a director of Visionsense, Ltd., a private
medical technology company, Advanced Biohealing Inc., a private
specialty biotechnology company, NoraRay Inc., a private medical
technology company, Neuro-Hitech, Inc. (NASD: NHPI), an early
stage pharmaceutical company and Comprehensive Neurosciences, a
psychiatric care and drug testing company.
|
|
(4)
|
|
Mr. Klatell served as Chief Executive Officer of DICOM
Group plc from December 2005 until his retirement in December
2007. Mr. Klatell served as Executive Vice President of
Arrow Electronics, Inc. from July 1995 until December 2003 and
served on the Board of Directors of Arrow Electronics, Inc. from
May 1989 to December 2003. Mr. Klatell is also Chairman of
the Board of Directors and Chairman of the Nominating and
Corporate Governance Committee of TTM Technologies, Inc.
|
|
(5)
|
|
Mr. Loughlin served nearly 40 years with KPMG LLP
until his retirement in 2003. From 1995 to 2003,
Mr. Loughlin served as a Global Lead Partner in KPMGs
Healthcare Practice. Mr. Loughlin also served as a member
of the Board of Directors of KPMG and as chairman of the Pension
and Investment Committee of the KPMG Board from 1995 to 2000. He
served as a non-Board member of the Pension and Investment
Committee thereafter until 2003. Mr. Loughlin is also a
member of the Board of Directors of Celgene Corporation and
Alfacell Corporation.
|
|
(6)
|
|
Mr. Wyman has served as an independent management
consultant since 1995. Mr. Wyman was a founding partner in
the consulting firm, Oliver, Wyman & Company, where he
served from 1984 to 1995. Previously, he served as President of
the Management Consulting Group at Booz, Allen &
Hamilton in a career that began there in 1965. He has served as
a director of 13 corporations, and is currently a director of
Pegasystems Inc., Allston Holding, LLC, and Dice, Inc.
|
THE
BOARD OF DIRECTORS AND BOARD COMMITTEES
As of the date of this Information Statement, the Datascope
Board has seven directors and maintains an audit committee, a
compensation committee and a nominations and corporate
governance committee. The current membership and the function of
each of these committees are described below. Other than
Messrs. Altschiller and Saper, each of our directors is
independent as defined under the National
Association of Securities Dealers, Inc.s listing
standards. Mr. Loughlin is the Lead Independent Director of
the Datascope Board.
During the fiscal year ended June 30, 2008 (
Fiscal
2008
), the Datascope Board held 15 meetings. Each of
the directors attended 75% or more of the aggregate number of
meetings of the Datascope Board and committees on which he
served. Directors are encouraged to attend the Annual Meeting of
Stockholders, and all members of the Datascope Board attended
Datascopes Annual Meeting of Stockholders in December
2007. There were also two consents executed outside of the
Datascope Board and committee meetings during Fiscal 2008.
The Datascope Board has an audit committee (the
Audit
Committee
) comprised of Messrs. Klatell,
Loughlin, Wyman and Dantzker. Each of the members of the Audit
Committee is independent as defined under the
National Association of Securities Dealers, Inc.s listing
standards. The primary functions of the Audit Committee are to
monitor the quality and integrity of the audits of
Datascopes financial statements, to monitor the financial
reporting process and systems of internal controls regarding
finance, accounting and legal and regulatory compliance, to
monitor the independence, qualification and performance of
Datascopes independent registered public accounting firm
and to provide an avenue of communication between the
independent registered public accounting firm, management and
the Datascope Board. The Audit Committee also receives
information generated by Datascopes anonymous system for
reporting violations of its ethics and
3
business practice policies. The Audit Committee held nine
meetings during Fiscal 2008. The Datascope Board has determined
that Mr. Loughlin is a financial expert and independent as
defined under applicable SEC rules.
The Datascope Board has a compensation committee (the
Compensation Committee
) comprised of
Messrs. Abramson, Klatell and Loughlin. Each of the members
of the Compensation Committee is independent as
defined under applicable National Association of Securities
Dealers, Inc.s listing standards. The primary
responsibilities of the Compensation Committee are to discharge
the Datascope Boards responsibilities relating to
compensation of executive officers, to produce an annual report
on executive compensation for inclusion in Datascopes
proxy statement and to oversee, review and advise the Datascope
Board on the adoption of policies that govern Datascopes
compensation, equity and employee benefit plans and programs.
The Compensation Committee held ten meetings during Fiscal 2008.
The Datascope Board has a nominations and corporate governance
committee (the
Nominating Committee
)
comprised of Messrs. Abramson, Klatell and Wyman. Each of
the members of the Nominating Committee is
independent as defined under applicable National
Association of Securities Dealers, Inc.s listing
standards. The primary objectives of the Nominating Committee
are to develop and recommend to the Datascope Board a set of
effective corporate governance policies and procedures
applicable to the Datascope Board, to identify individuals
qualified to become members of the Datascope Board and its
committees and to recommend to the Datascope Board the nominees
to stand for election as directors and to review and recommend
compensation of the members of the Datascope Board and its
committees. The Nominating Committee recommends candidates based
on their business experience, diversity and personal skills in
technology, finance, marketing, financial reporting and other
areas that are expected to contribute to an effective board of
directors. The Nominating Committee employs several methods to
identify candidates, which include obtaining recommendations for
candidates from members of the Datascope Board and management.
The Nominating Committee held three meetings during Fiscal 2008.
The Nominating Committee will consider stockholder
recommendations for director sent to the Nominating Committee,
Datascope Corp., 14 Philips Parkway, Montvale, New Jersey 07645,
Attention: Secretary. Any recommendation from a stockholder
should include the name, background and qualifications of such
candidate and should be accompanied by evidence of such
stockholders ownership of Datascopes common stock.
The charters of the Audit Committee, the Compensation Committee
and the Nominating Committee are posted on Datascopes
website at www.datascope.com. The Business Conduct Policy Guide
of Datascope, which covers all employees of Datascope, is also
posted on Datascopes website.
Stockholders who wish to contact an individual director, the
Datascope Board or a committee of the Datascope Board should
send their correspondence to Datascope Corp., 14 Philips
Parkway, Montvale, New Jersey 07645, Attention: Board of
Directors. Each communication should specify the applicable
addressee or addressees to be contacted as well as the general
topic of the communication. Datascope will initially receive and
process communications before forwarding them to the addressee.
Datascope generally will not forward to the directors a
stockholder communication that it determines to be primarily
commercial in nature or relates to an improper or irrelevant
topic or that requests general information about Datascope.
4
SECURITY
OWNERSHIP OF CERTAIN STOCKHOLDERS
The following table provides information as to each person who
is known to Datascope to be the beneficial owner of more than 5%
of Datascopes voting securities as of September 12,
2008 (unless otherwise indicated):
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
Nature of
|
|
|
Percent of
|
|
|
|
Beneficial
|
|
|
Common
|
|
Name and Address of Beneficial Owner(1)
|
|
Ownership(1)
|
|
|
Stock(2)
|
|
|
Lawrence Saper
|
|
|
2,869,562
|
(3)
|
|
|
17.5
|
%
|
Datascope Corp.
14 Philips Parkway
Montvale, New Jersey 07645
|
|
|
|
|
|
|
|
|
Ramius LLC
|
|
|
1,041,496
|
(4)
|
|
|
6.6
|
%
|
9 Lexington Avenue, 20th Fl.
New York, NY 10022
|
|
|
|
|
|
|
|
|
Barclays Global Investors UK Holdings Ltd.
|
|
|
939,543
|
(5)
|
|
|
5.9
|
%
|
1 Churchill Place
Canary Wharf
London X0 E14 5HP
|
|
|
|
|
|
|
|
|
AXA
|
|
|
917,590
|
(6)
|
|
|
5.8
|
%
|
25 Avenue Matignon
75008 Paris, France
|
|
|
|
|
|
|
|
|
Bank of America Corporation
|
|
|
843,003
|
(7)
|
|
|
5.3
|
%
|
100 North Tryon Street
Charlotte, NC 28255
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
This table identifies persons having sole voting and investment
power with respect to the shares set forth opposite their names
as of September 12, 2008, except as otherwise disclosed in
the footnotes to the table, according to information publicly
filed or furnished to Datascope by each of them.
|
|
(2)
|
|
Shares beneficially owned, as recorded in this table, expressed
as a percentage of the shares of Common Stock of Datascope
outstanding as of September 12, 2008. For purposes of
calculating Mr. Sapers beneficial ownership, any
shares issuable pursuant to options exercisable within
60 days of September 12, 2008 are deemed to be
outstanding.
|
|
(3)
|
|
Includes (i) 33,153 shares owned by trusts created by
Mr. Saper for his children and (ii) 3,150 shares
owned by Mr. Sapers wife. Also includes an option
owned by Mr. Saper to purchase 500,000 shares of
Common Stock, which is currently exercisable. Also includes
1,290,911 shares that Mr. Saper contributed to a
grantor retained annuity trust called the Saper-A Investment
Trust, which was created in July 2006 and 1,039,107 shares
contributed to a grantor retained annuity trust called the
Saper-B Investment Trust, which was created in May 2008
(collectively, the
Trusts
). Mr. Saper is
the trustee of the Trusts.
|
|
(4)
|
|
Ramius LLC (
Ramius
) is an Investment Adviser
registered under Section 203 of the Investment Advisers Act
of 1940, as amended (the
Advisers Act
). Based
solely on a Form 13F filed on August 15, 2008 by
Ramius and a Form 13F filed on August 15, 2008 by RCG
Starboard Advisors, LLC, Ramius, together with a group comprised
of Parche, LLC, Starboard Value and Opportunity Master
Fund Ltd., RCG Enterprise, Ltd., RCG Starboard Advisors,
LLC, C4S & Co., L.L.C., Peter A. Cohen, Morgan B.
Stark, Thomas W. Strauss and Jeffrey M. Solomon, has sole voting
and investment power with respect to 1,041,496 shares of
Common Stock.
|
|
(5)
|
|
Based solely upon a Form 13F filed with the SEC by Barclays
on July 25, 2008, Barclays Global Investors UK Holdings
Ltd. (
Barclays
), Barclays has shared
investment power with respect to 939,543 shares of Common
Stock, sole voting power with respect to 753,983 shares of
Common Stock and no voting power with respect to
185,560 shares of Common Stock.
|
|
(6)
|
|
Based solely upon a Form 13F filed with the SEC by AXA on
August 14, 2008, AXA has shared investment power with
respect to 917,590 shares of Common Stock, sole voting
power with respect to 576,912 shares of Common Stock, and
no voting power with respect to 340,678 shares of Common
Stock.
|
5
|
|
|
(7)
|
|
Bank of America (
BofA
) is a national
commercial bank corporation. Based solely on a Form 13F
filed by BofA on August 12, 2008, BofA has shared
investment power with respect to 843,003 shares of Common
Stock, sole voting power with respect to 625,152 shares of
Common Stock, shared voting power with respect to
81,365 shares of Common Stock and no voting power with
respect to 136,486 shares of Common Stock.
|
SECURITY
OWNERSHIP OF MANAGEMENT
The following table shows the number of shares of Common Stock
beneficially owned by Datascopes directors, the executive
officers identified in the summary compensation table below
(excluding Mr. Saper, whose holdings are shown in the
preceding table) and all directors and executive officers as a
group (including Mr. Saper) as of September 12, 2008:
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
Nature of
|
|
|
Percent of
|
|
|
|
Beneficial
|
|
|
Common
|
|
Name of Beneficial Owner(1)
|
|
Ownership
|
|
|
Stock(2)
|
|
|
Alan B. Abramson
|
|
|
27,101
|
(3)
|
|
|
*
|
|
David Altschiller
|
|
|
17,490
|
(4)
|
|
|
*
|
|
David Dantzker, M.D.
|
|
|
0
|
|
|
|
*
|
|
Robert E. Klatell
|
|
|
15,000
|
(5)
|
|
|
*
|
|
Timothy J. Krauskopf
|
|
|
10,000
|
(6)
|
|
|
|
|
Antonino Laudani
|
|
|
68,764
|
(7)
|
|
|
*
|
|
Boris Leschinsky
|
|
|
34,443
|
(8)
|
|
|
*
|
|
James J. Loughlin
|
|
|
11,000
|
(9)
|
|
|
*
|
|
Henry M. Scaramelli
|
|
|
31,760
|
(10)
|
|
|
*
|
|
William W. Wyman
|
|
|
8,904
|
(11)
|
|
|
*
|
|
All executive officers and directors as a group (consisting of
14 individuals)
|
|
|
3,221,604
|
(12)
|
|
|
19.4
|
%
|
|
|
|
*
|
|
Represents less than 1% of the shares of Common Stock of
Datascope outstanding as of September 12, 2008.
|
|
(1)
|
|
This table identifies persons having sole voting and investment
power with respect to the shares set forth opposite their names,
except as otherwise disclosed in the footnotes to the table,
according to information furnished to Datascope by each of them.
|
|
(2)
|
|
Shares beneficially owned, as recorded in this table, expressed
as a percentage of the shares of the Common Stock of Datascope
outstanding as of September 12, 2008. For the purpose of
calculating each persons beneficial ownership, any shares
issuable pursuant to options exercisable within 60 days of
September 12, 2008 are deemed to be beneficially owned by,
and outstanding with respect to, such person. An option is
considered to be exercisable within 60 days of
September 12, 2008 if the option has vested or will vest
within such period, even though by September 12, 2008 the
threshold price, which, depending on the option, may be a
condition for exercisability, may not have been reached.
|
|
(3)
|
|
Consists of 22,500 shares which are issuable pursuant to
currently exercisable options, 1,954 shares of restricted
stock issued on January 1, 2007 which vested on
January 1, 2008, 1,950 shares of restricted stock
issued on January 1, 2008, which will vest on
January 1, 2009 and 697 shares of restricted stock
issued on January 1, 2008, which vest ratably over a
12 month period.
|
|
(4)
|
|
Includes 15,000 shares which are issuable pursuant to
currently exercisable options.
|
|
(5)
|
|
Consists of 15,000 shares which are issuable pursuant to
currently exercisable options.
|
|
(6)
|
|
Consists of 10,000 shares which are issuable pursuant to
currently exercisable options.
|
|
(7)
|
|
Consists of 40,400 shares which are issuable pursuant to
currently exercisable options and 28,364 shares of
restricted stock. A restricted stock grant of 30,000 shares
was granted on August 22, 2007 and vests in four equal
annual installments of 25% on the anniversary of the grant date.
The above balance of
|
6
|
|
|
|
|
restricted shares reflects shares withheld for payment of taxes
on the first annual vesting date of August 22, 2008.
|
|
(8)
|
|
Includes 21,850 shares which are issuable pursuant to
currently exercisable options.
|
|
(9)
|
|
Includes 10,000 shares which are issuable pursuant to
currently exercisable options.
|
|
(10)
|
|
Includes 19,700 shares which are issuable pursuant to
currently exercisable options and 9,177 shares of
restricted stock. A restricted stock grant of 10,000 shares
was granted on August 22, 2007 and vests in four equal
annual installments of 25% on the anniversary of the grant date.
The above balance of restricted shares reflects shares withheld
for payment of taxes on the first annual vesting date of
August 22, 2008.
|
|
(11)
|
|
Consists of 5,000 shares which are issuable pursuant to
currently exercisable options, 1,954 shares of restricted
stock issued on January 1, 2007 and 1,950 shares of
restricted stock issued on January 1, 2008. The restricted
stock vests on the one year anniversary of the grant date.
|
|
(12)
|
|
Includes 768,900 shares which are issuable pursuant to
currently exercisable options.
|
EXECUTIVE
OFFICERS OF DATASCOPE
The following table sets forth the names, ages and all positions
and offices held by Datascopes present executive officers.
Unless otherwise indicated below, each person has held the
office indicated for more than five years:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
|
Positions and Offices Presently Held
|
|
Lawrence Saper
|
|
|
80
|
|
|
Chairman of the Board of Directors and Chief Executive Officer
|
Henry M. Scaramelli
|
|
|
55
|
|
|
Vice President, Finance and Chief Financial Officer(1)
|
Fred Adelman
|
|
|
55
|
|
|
Vice President, Chief Accounting Officer and Treasurer(2)
|
Nicholas E. Barker
|
|
|
50
|
|
|
Vice President, Corporate Design(3)
|
Robert O. Cathcart
|
|
|
48
|
|
|
Vice President; President, Interventional Products Division(4)
|
Timothy J. Krauskopf
|
|
|
47
|
|
|
Vice President, Regulatory and Clinical Affairs(5)
|
Antonino Laudani
|
|
|
49
|
|
|
Vice President and Chief Operating Officer(6)
|
Boris Leschinsky
|
|
|
43
|
|
|
Vice President, Technology(7)
|
|
|
|
(1)
|
|
Mr. Scaramelli has been employed by Datascope as Vice
President, Finance and Chief Financial Officer since August
2007. From September 2003 to August 2007, Mr. Scaramelli
served as Vice President, Corporate Controller and also served
as Acting Chief Financial Officer from April 2007 to August
2007. From June 2004 to the present, Mr. Scaramelli served
as Acting Vice President of Finance for the Interventional
Products Division and InterVascular, Inc. From July 2002 to
August 2003, Mr. Scaramelli served as Group Vice President,
Finance for the Cardiac Assist Division and InterVascular, Inc.
From October 1996 to June 2002, Mr. Scaramelli served as
Vice President, Finance for the Cardiac Assist Division.
|
|
(2)
|
|
Mr. Adelman has been employed by Datascope as Vice
President, Chief Accounting Officer since July 2002 and
Treasurer since May 22, 2008. From October 1999 to June
2002, he served as Corporate Controller. From July 1983 to
October 1999, Mr. Adelman was employed by Datascope as
Director of Corporate Accounting.
|
|
(3)
|
|
Mr. Barker has been employed by Datascope as Vice
President, Corporate Design since December 1997.
|
|
(4)
|
|
Mr. Cathcart has been employed by Datascope as Vice
President; President, Interventional Products Division since May
2005. Effective November 8, 2007, Mr. Cathcart has
also been serving as Vice President Sales, Cardiac Assist
Division (Acting). From November 2004 to April 2005, he served
as Vice President; President, Interventional
Products/InterVascular Group. From July 2004 to October 2004,
Mr. Cathcart served as Group Vice President of Sales for
Cardiac Assist, InterVascular and Interventional Products. From
October 2001 to June 2004, Mr. Cathcart served as Vice
President, Sales for the Cardiac Assist Division.
|
7
|
|
|
(5)
|
|
Mr. Krauskopf has been employed by Datascope as Vice
President, Regulatory and Clinical Affairs since February 2006.
Prior to joining Datascope, he served as Senior Vice President
for Regulatory and Clinical Affairs for Cardiac Assist, Inc.
from March 2002 to December 2005.
|
|
(6)
|
|
Mr. Laudani has been employed by Datascope as Vice
President and Chief Operating Officer since October 21,
2007. He served as Vice President; Group President, Cardiac
Assist and InterVascular from June 2007 to October 2007, and
President, InterVascular, Inc. since February 2005. From January
2005 to September 2006, he was Group Vice President of Sales for
Cardiac Assist, InterVascular and Interventional Products for
Europe, the Middle East and Africa (
EMEA
).
Effective September 2006, he was also responsible for sales of
Patient Monitoring products for EMEA. From June 2002 to December
2004, Mr. Laudani served as Vice President, Cardiac Assist
Sales for EMEA.
|
|
(7)
|
|
Mr. Leschinsky has been employed by Datascope as Vice
President, Technology since July 2005. From August 1990 until
June 2005, he served in various engineering positions in the
Research and Development Department of the Cardiac Assist
Division.
|
EXECUTIVE
COMPENSATION
The
Compensation Committee
Alan Abramson, Robert Klatell and James Loughlin are the members
of the Compensation Committee. Mr. Abramson, who has served
on the Compensation Committee for eleven years, is the
chairperson of the Compensation Committee. Each member of the
Compensation Committee is an independent director as defined
under applicable National Association of Securities Dealers,
Inc.s listing standards as well as the charter of the
Compensation Committee. The Compensation Committee is appointed
by the Datascope Board and is governed by a written charter
adopted by the Datascope Board. A copy of the charter is
available on Datascopes website at www.datascope.com.
The primary responsibility of the Compensation Committee is to
review, approve and administer Datascopes compensation
programs and to review and approve the compensation of the
executive officers of Datascope, including base salary, annual
cash bonus, long-term cash incentives, equity-based incentive
compensation,
change-in-control
benefits, perquisites and general benefits.
As set forth in its charter, the Compensation Committee
determines which employees are executive officers
whose compensation is subject to its review and approval. The
Compensation Committee has determined that the executive
officers for this purpose are the Chief Executive Officer
(the
CEO
), each of the CEOs direct
reports and the head of each division. All of the named
executive officers are executive officers as
determined by the Compensation Committee. In addition, the
Compensation Committee also reviewed the compensation and
termination package of Adam Saper, Director of Business
Development, Patient Monitoring Division, who is the son of
Lawrence Saper, the CEO.
Compensation
Committee Interlocks and Insider Participation
No person who served as a member of the Compensation Committee
during Fiscal 2008 was a current or former officer or employee
of Datascope or engaged in certain transactions with Datascope
required to be disclosed by regulations of the SEC.
Additionally, there were no Compensation Committee
interlocks during Fiscal 2008 which generally means
that no executive officer of Datascope served as a director or
member of the Compensation Committee of another entity, one of
whose executive officers served as a director or member of the
Compensation Committee.
The
Compensation Committee Process
Datascopes compensation process for executive officers
involves both the Compensation Committee and certain members of
senior management, principally the CEO, the Chief Financial
Officer, the Chief Operating Officer and the Vice President,
Human Resources. These members of management principally assist
the
8
Compensation Committee in establishing business performance
targets and objectives, evaluating the performance of employees
and recommending salary levels, cash incentive awards and equity
awards for executive officers. They present the Compensation
Committee with historical breakdowns of the components of
compensation for each executive officer, as well as the total
compensation earned, and make recommendations for each executive
officers overall compensation package for the following
fiscal year. The CEO provides an evaluation of the performance
of the senior executive officers, including the named executive
officers but excluding himself. The Compensation Committee
reviews the recommendations of the CEO carefully in light of his
working relationship with the other executives and his direct
knowledge of their contributions to and goals for continuing
achievement with Datascope. In evaluating the performance of the
executive officers, the Compensation Committee does not rely
solely on predetermined formulas or a limited set of criteria
and may accord different weight at different times to different
factors for each executive officer.
Pursuant to the charter of the Compensation Committee, the
Compensation Committee has the authority to select and retain
consultants. The Compensation Committee engaged Pearl
Meyer & Partners (
PM&P
), an
independent consulting firm, as its compensation consultant
beginning in 2006 to assist the Compensation Committee in
considering future executive compensation. Under the terms of
its engagement, PM&P reports to and may only accept
assignments approved by the Compensation Committee. The
Compensation Committee has from time to time requested PM&P
to identify specific peer groups of companies, to provide
research regarding compensation programs and compensation levels
among the companies in the peer groups, to perform market
benchmarking compensation studies, to assist the Compensation
Committee in evaluating the design of the compensation programs
and to provide ongoing advice with respect to the compensation
programs for the executive officers and non-employee directors.
In May 2007 (for Fiscal 2008), PM&P conducted a competitive
market review of the CEOs compensation. In May 2006 (for
the fiscal year ended June 30, 2007 (
Fiscal
2007
)), PM&P conducted a competitive market
review of the compensation for the CEO and each of the other
named executive officers based on analysis of the compensation
practices of general industry peer companies and CEO Founders
Data (defined below), as well as several broad-based general
industry compensation surveys. At the direction of the
Compensation Committee, PM&P meets with management to
receive and review the information received from management.
The Compensation Committees process for determining
compensation for the executive officers generally begins with
management presenting to the Compensation Committee its
compensation proposal. The Compensation Committee evaluates the
proposal in light of the information provided by PM&P and
may discuss the proposal with PM&P to obtain its input. If
the proposal is acceptable to the Compensation Committee it will
then approve it, with such adjustments to the terms of the
proposal to the extent the Compensation Committee deems
advisable. If applicable, the Compensation Committee will then
submit the proposal, as so adjusted with any changes deemed
advisable by the Compensation Committee, to the Datascope Board
and, if required or advisable, to stockholders of Datascope for
their approval.
The Compensation Committee meets as often as needed to perform
its responsibilities. In Fiscal 2008, Compensation Committee
held ten meetings. The Compensation Committee communicates with
management to develop the meeting agenda in advance of each
meeting and members of management are often invited by the
Compensation Committee to participate in meetings. The
Compensation Committee also meets with Dechert LLP, outside
counsel to Datascope, and PM&P. The Compensation Committee
periodically meets in executive sessions without management.
Although many compensation decisions are made in the first
quarter of the fiscal year, the compensation planning process
continues throughout the year. Business planning, evaluation of
management performance and of compensation programs,
consideration of the business environment and monitoring of
compensation programs offered by comparable companies and
companies in our industry are performed throughout the fiscal
year as the Compensation Committee determines is necessary.
Information
Provided by Compensation Consultants
The Compensation Committee, together with PM&P, reviews
from time to time benchmarking data with regard to its executive
officer positions and annually reviews such data with regard to
the compensation of its
9
CEO. In May 2007 (for Fiscal 2008), PM&P conducted a
competitive market review of the CEOs compensation. In May
2006 (for Fiscal 2007), PM&P conducted a competitive market
review of the compensation for the CEO and each of the other
named executive officers based on analysis of the compensation
practices of general industry peer companies and CEO Founders
Data (defined below), as well as several broad-based general
industry compensation surveys. In reviewing the broad-based
compensation survey data, the Compensation Committee does not
consider the specific survey participants to be material to its
compensation determination process. In light of Datascopes
proposed transaction with Purchaser and Parent, salaries of
executive officers have not yet been established for Fiscal
2008, and PM&P has not been asked to conduct a competitive
market review in 2008 (for the fiscal year ended June 30,
2009 (
Fiscal 2009
)), although PM&P did
provide some competitive market data in connection with the
Compensation Committees approval of
Mr. Laudanis compensation package during Fiscal 2008.
The Compensation Committee considers the competitiveness of our
overall compensation arrangements in relation to a peer group of
comparable medical device companies identified by PM&P. The
Compensation Committee reviews compensation levels for our named
executive officers, including the CEO, compared to executive
compensation levels at the peer group companies. The
Compensation Committee, with the assistance of PM&P,
regularly reviews the composition of the peer group. During
Fiscal 2008, the peer group consisted of the following companies:
|
|
|
|
|
Arrow International, Inc.
|
|
|
|
ArthroCare Corporation
|
|
|
|
Biomet, Inc.
|
|
|
|
Biosite Incorporated (this company has since been acquired)
|
|
|
|
C.R. Bard, Inc.
|
|
|
|
CONMED Corporation
|
|
|
|
Haemonetics Corporation
|
|
|
|
Integra LifeSciences Holdings
|
|
|
|
Mentor Corporation
|
|
|
|
Thoratec Corporation
|
|
|
|
Viasys Healthcare Inc.
|
|
|
|
Wright Medical Group, Inc.
|
These peer companies have been selected to represent
Datascopes competitive market based on their industry
focus, business mix, sales size and number of employees.
Although some larger direct competitors have been included,
Datascope is comparable in sales size with the peer group median.
For Fiscal 2007, PM&P has also provided the Compensation
Committee with reports regarding two supplemental reference
groups that were similar to Datascope in terms of sales and
market capitalization: (1) a comparator group
of general industry companies; and (2) a group of companies
in which the founding CEO held at least 5% beneficial ownership
of each companys equity (
CEO Founders
Data
).
Although the Compensation Committee reviews data pertaining to
the above-described peer group, the Compensation Committee
recognizes the difficulty in choosing a group of publicly-traded
companies that has market capitalization, size and business mix
that all closely match that of Datascope. Therefore, although
the Compensation Committee reviews data pertaining to our
identified peer group, the Compensation Committee does not
believe that it is appropriate to establish compensation levels
primarily based on benchmarking. Furthermore, the Compensation
Committee does not target a certain percentile or the median for
each compensation element shown in our peer group, but rather
considers the total compensation of our executive officers.
Nonetheless, the Compensation Committee recognizes that
Datascopes compensation practices must be competitive in
the marketplace to attract and retain highly qualified key
executive officers. Therefore, this
10
marketplace information is one of the many factors that the
Compensation Committee considers in assessing the reasonableness
of compensation. In addition to compensation data for its peer
group, the Compensation Committee also considers information
from other sources, such as compensation survey data, individual
performance, CEO Founders Data (especially with respect to
long-term compensation), data from the comparator group,
compensation data for executives at larger competitors in the
medical devices industry, year-to-year financial and stock
performance, progress towards strategic objectives of Datascope
and the individuals compensation levels relative to that
of other executives of Datascope. With regard to the
compensation level of our CEO, the Compensation Committee also
considers the unique contributions of a founding CEO, his status
as a founder and his holdings of Common Stock.
Compensation
Discussion and Analysis
Compensation
Objectives
The objective of the Compensation Committee in setting
Datascopes compensation policy is to provide compensation
packages that will allow Datascope to:
|
|
|
|
|
attract, motivate and retain highly qualified executive officers;
|
|
|
|
align the financial interests of each executive officer with the
interests of the stockholders by focusing on annual and
long-term performance factors that drive stockholder value;
|
|
|
|
reward executive officers for attaining desired levels of profit
and stockholder value; and
|
|
|
|
reinforce each executive officers stake in
Datascopes long-term performance and success.
|
What
Our Compensation Program is Designed to Reward
Overall, the compensation program is designed to reward
individual, divisional and company short-term and long-term
performance. A portion of the compensation opportunity for the
executive officers is comprised of a combination of annual cash
bonuses, which reward annual executive, divisional and company
performance, and long-term cash incentives and, in certain
cases, restricted stock awards, which reward long-term growth in
company net earnings performance. The Compensation Committee
believes that by weighting total compensation in favor of the
performance-based components of the total compensation program,
the Compensation Committee appropriately rewards individual
achievement while at the same time providing incentives to
promote company performance (see Compensation of the
CEO below for a discussion of the weighting of CEO
compensation). Because the Committee has established aggressive
targets for its bonus program, bonuses have been small in recent
years and a significant portion of compensation has been in the
form of salary.
The Compensation Committee does not use fixed percentages to
determine the mix of base salary, bonus and long-term incentive
components. Instead, it sets cash compensation, including base
salaries at levels that are competitive with peer group
companies and with the medical device industry. The Compensation
Committee then offers annual bonus and long-term incentive
opportunities based on factors such as the individuals
position and responsibilities, specific divisional and
performance goals tied to the individuals position and the
historic compensation of executive officers in Datascope.
In recent years, the Compensation Committee has made two
significant changes to its compensation philosophy. First, the
Compensation Committee, after consultation with senior
management, determined that those members of management who have
the ability to have the most meaningful impact on
Datascopes operations and growth should participate in
incentive programs. This change was effected in order to provide
meaningful potential incentives while assuring that the
appropriate portion of earnings is retained for the benefit of
Datascope and stockholders. To this end, the breadth of employee
participation in Datascopes incentive programs was reduced
(though the participation of the executive officers in these
programs was not significantly affected). Second, the
Compensation Committee has reduced the number and size of stock
option awards in favor of cash bonuses, restricted stock grants
and performance-based cash long term incentive plans. For many
years, stock options were the principal form of long-term
incentives awarded to employees. The Compensation Committee has
concluded that stock options are not currently an effective
method of promoting
11
long-term equity ownership in Datascope because option holders
have tended to sell the shares underlying the options
immediately upon exercise. Recent accounting changes also
require the cost of stock options to be expensed, decreasing the
relative accounting benefits of stock options as compared to
restricted stock awards. In addition, Datascope believes that it
can achieve the same benefits by granting fewer restricted
shares than options, as well as by using performance-based cash
long-term incentive plans, thereby reducing the dilution to
stockholders and strengthening the link between pay and
long-term performance.
Proposed
Merger with Getinge
Pursuant to the Merger Agreement, Datascope agreed to certain
restrictive covenants as to the activities of Datascope and its
subsidiaries during the period from the date of the Merger
Agreement to the earlier of the Appointment Time and the
termination of the Merger Agreement. These covenants provide
that, subject to certain exceptions, Datascope will not take
certain actions without the prior written consent of Parent,
including, among other things: (1) issuing, granting or
awarding any right to acquire shares of Common Stock, or any
options, warrants, convertible securities or any other rights to
acquire or receive any shares of its Common Stock;
(2) issuing any additional shares of Common Stock except
pursuant to the exercise of stock options or other awards
outstanding on the date of the Merger Agreement under
Datascopes plans; (3) increasing the compensation
(including increasing any bonus opportunities) or benefits of
any of Datascopes director and officers; (4) paying
or granting any pension, severance, termination or retirement
benefits not required by any existing plan or agreement, except
with respect to such benefits provided to new hires of Datascope
in the ordinary course of business; and (5) establishing,
amending in any material respect, entering into to terminating
any material plan except as reasonably determined by Datascope
to be appropriate to comply with applicable laws or as may be
provided to new hires consistent with past practice. In light of
Datascopes proposed transaction with Purchaser and Parent,
the Compensation Committee has deferred certain decisions with
respect to determining compensation for executive officers for
Fiscal 2009 until further clarity on the timing for the
consummation of the transaction is known. It is anticipated that
any compensation decisions, once made, will be made in
accordance with the provisions of the Merger Agreement.
Elements
of Executive Compensation
The compensation program for executive officers consists of the
following elements of compensation, each described in greater
depth below:
|
|
|
|
|
base salaries;
|
|
|
|
annual cash bonuses;
|
|
|
|
long-term cash incentives;
|
|
|
|
equity-based incentive compensation;
|
|
|
|
change-in-control
benefits;
|
|
|
|
perquisites; and
|
|
|
|
general benefits.
|
As noted above, a significant portion of executive compensation
is determined based on the Compensation Committees
evaluation of Datascopes and each executive officers
annual and long-term performance. Datascope provides few
personal benefits to executive officers, such as a monthly
allowance for automobile expenses or a company-leased
automobile. Datascope also provides
change-in-control
benefits as a recruitment and retention mechanism. Finally,
other than an executive medical plan available to executive
officers, executive officers participate in Datascope benefit
plans that are offered to all employees, including
Datascopes 401(k) savings plan, health and benefit plans,
and are entitled to vacation and paid time off based on
Datascopes general vacation policies.
12
Base
Salary
Base salaries are a critical element of executive compensation
because they are essential to recruiting and retaining qualified
employees and provide executive officers with a base level of
monthly income. Base salaries are initially set by the
Compensation Committee with managements input. In
determining base salary levels, the Compensation Committee
considers the executive officers position with Datascope,
his or her qualifications and experience, past performance,
scope of responsibilities, goals and objectives set for the
executive officer and whether or not the base salary would be
tax deductible. The Compensation Committee also considers salary
levels for similar positions at comparable companies. With
regard to hiring executive officers, Datascope competes with
many companies that are significantly larger in size and with
greater resources, and, therefore, the Compensation Committee
seeks to offer competitive base salaries to attract and hire
highly qualified executive officers.
Thereafter, the Compensation Committee reviews salary levels in
the first quarter of each fiscal year and considers potential
increases in base salary each year based on its subjective
assessment of Datascopes overall performance over the
preceding year, as well as executive officer performance and
experience, length of service and changes in responsibilities.
As part of its review, the Compensation Committee receives
reports from the CEO regarding recommendations in salary
adjustments for executive officers. When conducting its review,
the Compensation Committee obtains market information from
PM&P about compensation levels for executives. In light of
Datascopes proposed transaction with Purchaser and Parent,
salaries for executive officers have not been adjusted from
their salaries in Fiscal 2008, other than upon
Mr. Laudanis promotion, and PM&P has not been
asked to obtain market information for positions other than the
CEO and positions similar to Mr. Laudanis. Also
included in the subjective determination is the Compensation
Committees evaluation of the development and execution of
strategic plans, the exercise of leadership and involvement in
industry groups. For example, Mr. Laudani represents
Datascope in the European Association of Medical Devices
Manufacturers, Mr. Barker is a member of the Industrial
Design Association of America and Mr. Leschinsky is a
member of the American Society for Artificial Internal Organs.
The weight given such factors by the Compensation Committee may
vary from one executive officer to another.
See Compensation of the CEO below for a discussion
of the base salary of the CEO.
Salary increases for the executive officers are typically
determined in August of each fiscal year and become effective in
October for such fiscal year. The Compensation Committee reviews
the base salaries of executive officers holding positions of
similar levels within the peer group selected by PM&P, as
well as the performance of their respective divisions. In light
of Datascopes proposed transaction with Purchaser and
Parent, the salaries of the named executive officers have not
yet been adjusted from their salaries in Fiscal 2008, although
such an increase may occur based on the Committees
consideration of the performance of the respective divisions
that these officers lead. Additionally, PM&P has not been
asked to review peer group compensation data (other than for
Mr. Laudani) in Fiscal 2008 (for Fiscal 2009).
2004
Management Incentive Plan
To support Datascopes goals of rewarding the performance
of executive officers and aligning the interest of executive
officers with those of Datascopes stockholders, the
Compensation Committee awards cash bonuses to named executive
officers under the Datascope Corp. 2004 Management Incentive
Plan, which was approved by stockholders in December 2003 (the
Incentive Plan
). Awards are based on the
attainment of overall corporate and division financial
thresholds and targets and certain subjective individual
criteria. In the case of Mr. Saper, the threshold and
targets are limited to objective financial criteria,
historically earnings per share of Datascope. The Compensation
Committee has determined that operating results, such as
earnings per share, are the best measures of executive
performance, because these types of metrics motivate the
executive officers to focus their efforts on improving
Datascopes overall performance. To ensure that the
objectives of the CEO and senior management are aligned, the
corporate financial thresholds and targets use earnings per
share as the performance metric and the thresholds and targets
are the same for both the CEO and senior management.
13
The thresholds and targets are generally established within the
first 25% of the measurement period by the Compensation
Committee. The thresholds, targets and formulas for calculation
of whether the thresholds and targets are achieved are submitted
by management, which the Compensation Committee considers,
adjusts in its discretion and subsequently approves, subject to
any adjustments deemed advisable by the Compensation Committee.
Bonuses are granted to participants if the thresholds are
achieved, and the size of the executive officers bonus
increases with the level of achievement up to a certain maximum
level of bonus. However, the Compensation Committee has the
discretion to (i) decrease or eliminate the award payable
to any executive (such as Mr. Saper) who is covered by
Section 162(m) of the Internal Revenue Code (the
Code
), or (ii) increase, decrease or
eliminate the award payable to any executive officer to reflect
the individual performance and contribution of, and other
factors relating to, such executive officer. At the end of the
fiscal year, the Compensation Committee reviews Datascopes
performance to determine whether the thresholds and targets have
been met and ensures that the Incentive Plan is appropriately
administered. The Compensation Committee determines in its
discretion whether and how much cash bonus to pay each executive
officer based on its review of company and individual
performance. As a result of the pending acquisition of
Datascope, the Compensation Committee has not yet determined
thresholds, targets and formulas for Fiscal 2009.
If the overall performance targets are not met in any given
measurement period, the Compensation Committee, in consultation
with the CEO, has the discretionary authority to approve bonus
awards outside of the 2004 Management Incentive Plan for
executive officers who have made substantial contributions
during such period. The aggregate amounts of these discretionary
bonus awards are typically lower than the amounts that would
have been granted to officers if Datascope had met its
performance targets. Depending on the Compensation
Committees assessment, bonuses may be equal to, more or
less than the previously established target amounts.
Performance targets are based on the operating results of
Datascopes core business and generally exclude special
items of income and expense that, in the judgment of the
Compensation Committee, are less relevant to the creation of
long-term value for Datascopes stockholders. The
Compensation Committee establishes targets at levels that it
believes would require superior performance from each executive
officer.
In Fiscal 2008, Datascope met its performance targets and
bonuses were awarded pursuant to the Incentive Plan. In Fiscal
2008, Datascope recognized gains in connection with the sale of
the Patient Monitoring business that would have resulted in
maximum bonuses being paid. The Compensation Committee adjusted
the targets for Fiscal 2008 to eliminate these gains and to
reflect the changes in Datascopes operations resulting
from the sale of the Patient Monitoring business during Fiscal
2008. Based on Fiscal 2008 performance, the following named
executive officers were granted bonuses: Lawrence Saper
$496,495, Antonino Laudani $250,000, Henry A. Scaramelli
$85,000, and Boris Leschinsky $65,000. These bonuses were
awarded based on the superior performance of the respective
divisions as well as the overall performance of Datascope.
Mr. Laudanis bonus was awarded based on his
compensation plan when he assumed the position of Chief
Operating Officer in October 2007. All awards for executive
officers are recommended by management and individually reviewed
and approved by the Compensation Committee.
Based on its evaluation of individual performance, the
Compensation Committee also reviewed and approved certain
bonuses in addition to those awarded under the Incentive Plan
for two named executive officers. Mr. Laudani also received
a bonus of $189,240 related to the sale of the Patient
Monitoring business and a bonus of $52,608 paid in Fiscal 2008
based on commercial results of Datascopes Europe, Middle
East and Africa business. Mr. Scaramelli also received a
discretionary bonus of $91,000 in recognition of the additional
work required during the sale of the Patient Monitoring business.
Long-Term
Incentive Plan
The Long-Term Incentive Plan, approved by the Datascope Board on
September 12, 2006 (the
Long-Term Incentive
Plan
), allows for cash awards to designated executives
and senior managers whose positions enable them to manage,
invest, develop or negotiate opportunities that contribute
directly to the growth of Datascopes earnings. Datascope
and the Compensation Committee believe that this plan
appropriately rewards executive officers who contribute to the
strategic growth, financial strength and long-term success of
Datascope. The initial
14
implementation of the plan measures results from
Datascopes fiscal years 2007 through 2009. An additional
three-year award measures results from Datascopes fiscal
years 2008 through 2010. Although a new three-year measurement
period will generally commence in each subsequent year
thereafter, in light of Datascopes proposed transaction
with Purchaser and Parent, the Datascope Board has not yet
approved a Long-Term Incentive Plan for fiscal years 2009
through 2011. Datascopes performance objectives under the
Long-Term Incentive Plan for the three-year period ending
June 30, 2009 and the three-year period ending
June 30, 2010 are specified levels for the compound annual
growth rate (
CAGR
) of consolidated net
earnings, excluding special items. The Long-Term Incentive Plan
specifies threshold, target and maximum levels of CAGR that will
determine the cash amount payable under the plan. The
Compensation Committee assigned participants a target amount, a
percentage of base pay used to calculate benefits under the
plan, which ranged from 30% to 40% of base pay. Under the
Long-Term Incentive Plan, a participant can receive from 0% to
200% of the applicable target amount, depending on
Datascopes actual CAGR of consolidated net earnings,
excluding special items. To date, the CEO has not participated
in the Long-Term Incentive Plan. Each of the other named
executive officers participates in the Long-Term Incentive Plan
for the three-year period ending June 30, 2009 and the
three-year period ending June 30, 2010.
Equity
Compensation
The Compensation Committee believes that, in addition to
compensating executive officers for the
long-term
performance of Datascope, the periodic grant of equity-based
compensation helps align the interest of the executive officers
with those of Datascopes stockholders, thereby ensuring
that such officers have a continuing stake in our long-term
success.
The Datascope Corp. 2005 Equity Incentive Plan (the
2005 Equity Incentive Plan
) allows for awards
to executives, certain types of which are based on the
attainment of performance objectives specified in the grant. The
performance objectives may be based on company-wide objectives
or objectives that are related to the performance of the
executive or the department or function within Datascope in
which the executive is employed. These objectives may be
measured on an absolute basis or a relative basis, which is
measured in relation to a group of peer companies or a financial
market index. These grants may specify a minimum level below
which no payment will be made and may set forth a formula for
determining the amount of any payment to be made if performance
is above the minimum acceptable level. The Compensation
Committee may also grant stock appreciation rights, restricted
shares, deferred shares and stock options under the 2005 Equity
Incentive Plan. In light of Datascopes proposed
transaction with Purchaser and Parent and pursuant to the terms
of the Merger Agreement, Datascope has agreed not to make new
equity awards pending the consummation of the Merger.
Datascope has recently used restricted stock rather than stock
options as an equity incentive. When restricted stock or stock
options are granted, they are generally granted at regularly
scheduled meetings of the Compensation Committee. A grant of
30,000 shares of restricted stock was made to
Mr. Laudani in August 2007 in recognition of his
performance as Vice President and Group President, Cardiac
Assist and InterVascular, which position he had assumed in June
2007. A grant of 10,000 shares of restricted stock was made
to Mr. Scaramelli in August 2007 in recognition of his
promotion to Vice President, Finance and Chief Financial Officer
in August 2007. Datascope does not have a program, plan or
practice to time option grants in coordination with the release
of material, non-public information, nor does Datascope plan to
time, nor has it timed, its release of material, non-public
information for the purpose of affecting the value of executive
compensation.
Change-in-Control
Benefits
When a
change-in-control
is contemplated, named executive officers may face an uncertain
future with Datascope after a
change-in-control
of Datascope. Datascope has entered into certain
change-in-control
agreements in order to diminish the extent to which the
possibility of a
change-in-control
would otherwise distract these employees and allow the executive
officers to provide effective management and continuity during a
period in which a
change-in-control
is contemplated. The material terms of Datascopes
15
change-in-control
benefits are described in the narrative section under the
caption Potential Payments Upon Termination or
Change-in-Control.
Perquisites
In 2008, Datascope provided executive officers with perquisites
and other personal benefits that the Compensation Committee
believed to be reasonable and consistent with the objective of
allowing Datascope to attract and retain highly qualified
officers. The cost to Datascope of the perquisites received by
our named executive officers in Fiscal 2008 is included in the
Summary Compensation Table below and described in the respective
footnotes.
Named executive officers have the option of receiving a monthly
allowance for expenses related to their automobiles or receiving
a company-leased automobile. The value of this perquisite is
included in the Summary Compensation Table below. We believe
that this type of perquisite is important as part of a total
compensation package when recruiting executive officers.
Datascope reimburses Mr. Saper for the cost of annual
country club membership dues. Datascope provides an automobile
and a driver for use by Mr. Saper for business purposes.
Datascope paid for the costs of tax and estate planning advice
received by Mr. Saper in Fiscal 2007 and the Committee
discontinued this perquisite for Fiscal 2008.
Compensation
of the CEO
The compensation arrangement with Mr. Saper reflects what
the Compensation Committee believes to be his unique history
with, role in, and contribution to, Datascope. Mr. Saper
founded Datascope and continues to be its largest stockholder.
He is responsible for, or has contributed to the development of,
most of Datascopes principal products, for which
Mr. Saper neither receives royalties nor special
compensation. As is discussed in greater detail below, because
of his age and length of service with Datascope, if
Mr. Saper elected to retire, his fully vested retirement
benefits would substantially exceed his compensation. Datascope
has entered into an employment agreement with Mr. Saper,
dated as of July 1, 1996 (as amended, the
Saper
Employment Agreement
). The Saper Employment Agreement
is for a term of five years and automatically renews unless
either party gives notice of intent not to continue to extend
the term. The Saper Employment Agreement provides for an annual
base salary and increases to the base salary as determined by
the Datascope Board or the Compensation Committee. On
September 22, 1999, the Compensation Committee determined
to set Mr. Sapers annual base salary at $1,000,000,
and the Compensation Committee has maintained
Mr. Sapers annual base salary at this level. In
consultation with PM&P, the Compensation Committee
determined that the total compensation package provided an
appropriate value for Mr. Sapers contribution to, and
role in, Datascope. Mr. Sapers total compensation is
heavily weighted toward salary and annual bonuses when, and if,
earned under the Incentive Plan because the Compensation
Committee determined that Mr. Sapers significant
stock ownership in Datascope creates compelling long-term
incentives, rendering other long-term incentives unnecessary.
Mr. Saper was not granted a bonus in connection with the
sale of the Patient Monitoring business and is not expected to
be granted a bonus in connection with the Merger.
Mr. Sapers compensation for Fiscal 2008 was
determined pursuant to the Saper Employment Agreement. Also
under the Saper Employment Agreement, Mr. Saper will be
required to pay Datascope $260,000, which represents the amount
that Datascope advanced to Mr. Saper in March 2002 for
payment of a membership deposit to a country club, upon the
termination of Mr. Sapers membership in the country
club or, if earlier, upon the termination of
Mr. Sapers employment with the Corporation; this
amount may be offset against amounts that Datascope owes to
Mr. Saper and any imputed interest on such advance is
treated as compensation. Mr. Saper may terminate the Saper
Employment Agreement for good reason, including a significant
breach by the Corporation of its obligations thereunder or
certain changes in control of the Corporation.
The overall compensation included in the employment agreement
paid to Mr. Saper was determined in a manner the
Compensation Committee believes is reflective of
Datascopes operating results, the growth in
Datascopes business and the value of Datascopes
equity, and recognizes the key role in, and contributions of
Mr. Saper to, the success of Datascope and its performance.
16
Mr. Saper is also entitled to certain retirement benefits.
See Potential Payments upon Termination or
Change-in-Control.
Since Mr. Saper has not historically received long-term
incentive compensation, the Compensation Committee believes that
it is appropriate for Mr. Saper to receive retirement
benefits, which it considers another form of compensation, in
light of his role and contributions to Datascope.
Mr. Sapers retirement benefits were established by
the Compensation Committee on May 20, 1997 and the
Compensation Committee has not made any increases to the
retirement benefits since that time.
Financial
Restatement
It is the Datascope Boards policy that the Compensation
Committee will, to the extent permitted by applicable law, have
the sole and absolute authority to make retroactive adjustments
to any cash or equity-based incentive compensation paid to
executive officers and certain other officers where the payment
was predicated upon the achievement of certain financial results
that were subsequently the subject of a restatement. Where
applicable, Datascope will seek to recover any amount determined
to have been inappropriately received by the individual
executive officer.
Tax
and Accounting Considerations
Datascope generally seeks to maximize the deductibility for tax
purposes of all elements of compensation. Section 162(m) of
the Code generally disallows a tax deduction for compensation
over $1,000,000 paid to Datascopes CEO and certain other
highly compensated executive officers. Qualifying
performance-based compensation will not be subject to the
deduction limit if certain requirements are met. The Incentive
Plan was approved by stockholders and contains the provisions
necessary so that amounts payable to Mr. Saper and the
named executive officers under the Incentive Plan will not be
subject to the deduction limitations of Section 162(m) of
the Code. The Compensation Committee reviews compensation plans
in light of applicable tax provisions and may recommend
amendments to compensation plans to maximize tax deductibility.
However, the Compensation Committee may approve compensation
that does not qualify for deductibility when the Compensation
Committee deems it to be in the best interests of Datascope and
its stockholders.
The Compensation Committee also considers the effect of certain
accounting rules on the various compensation programs that it
offers to executive officers. The Committee balances potential
accounting effects with the flexibility it needs to retain in
order to take any compensation actions that it determines are in
the best interests of Datascope and its stockholders.
Compensation
Committee Report
The Compensation Committee has reviewed and discussed the
foregoing Compensation Discussion and Analysis required by
Item 402(b) of
Regulation S-K
with management. Based on its review and discussion with
management, the Compensation Committee has recommended to the
Datascope Board that the Compensation Discussion and Analysis be
included in this Information Statement.
Compensation Committee:
Alan Abramson, Chairperson
Robert E. Klatell
James J. Loughlin
17
SUMMARY
COMPENSATION TABLE
The following table sets forth for Fiscal 2007 and Fiscal 2008,
the compensation paid to or earned by (i) our principal
executive officer, (ii) our principal financial officer,
(iii) the other three most highly compensated executive
officers of Datascope who were serving as executive officers as
of June 30, 2008 and (iv) an executive officer who
left Datascope during Fiscal 2008 who was among the most highly
compensated executive employees in Fiscal 2008 (collectively,
the
Named Executive Officers
):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name and Principal Position
|
|
Year
|
|
|
Salary ($)
|
|
|
Bonus ($)
|
|
|
Awards ($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)(1)
|
|
|
($)
|
|
|
Lawrence Saper
|
|
|
2008
|
|
|
|
1,000,000
|
|
|
|
496,495
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
189,320
|
(2)
|
|
|
514,505
|
|
|
|
2,200,320
|
|
Chairman of the Board of Directors and Chief Executive Officer
|
|
|
2007
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,067,621
|
(2)
|
|
|
503,154
|
|
|
|
2,570,775
|
|
Antonino Laudani(3)
|
|
|
2008
|
|
|
|
530,630
|
|
|
|
491,848
|
(4)
|
|
|
171,261
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
111,101
|
|
|
|
1,304,840
|
|
VP and Chief Operating Officer
|
|
|
2007
|
|
|
|
371,596
|
|
|
|
183,165
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,957
|
|
|
|
615,718
|
|
Henry M. Scaramelli
|
|
|
2008
|
|
|
|
257,500
|
|
|
|
176,000
|
(6)
|
|
|
57,087
|
|
|
|
|
|
|
|
|
|
|
|
10,800
|
|
|
|
22,930
|
|
|
|
524,317
|
|
VP; Finance and Chief Financial Officer
|
|
|
2007
|
|
|
|
230,000
|
|
|
|
60,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,254
|
|
|
|
17,016
|
|
|
|
342,270
|
|
Timothy J. Krauskopf
|
|
|
2008
|
|
|
|
259,250
|
|
|
|
62,000
|
|
|
|
|
|
|
|
42,900
|
|
|
|
|
|
|
|
19,706
|
|
|
|
48,844
|
|
|
|
432,700
|
|
VP; Regulatory and Clinical Affairs
|
|
|
2007
|
|
|
|
217,500
|
|
|
|
45,000
|
(7)
|
|
|
|
|
|
|
44,500
|
|
|
|
|
|
|
|
|
|
|
|
85,450
|
|
|
|
392,450
|
|
Boris Leschinsky
|
|
|
2008
|
|
|
|
226,250
|
|
|
|
65,000
|
|
|
|
|
|
|
|
43,100
|
|
|
|
|
|
|
|
443
|
|
|
|
81,533
|
|
|
|
416,326
|
|
VP, Technology
|
|
|
2007
|
|
|
|
211,250
|
|
|
|
25,000
|
|
|
|
|
|
|
|
43,158
|
|
|
|
|
|
|
|
17,097
|
|
|
|
85,469
|
|
|
|
381,974
|
|
David A. Gibson
|
|
|
2008
|
|
|
|
257,500
|
|
|
|
90,000
|
(9)
|
|
|
|
|
|
|
199,798
|
|
|
|
|
|
|
|
822
|
|
|
|
83,950
|
|
|
|
632,070
|
|
VP; President, Patient Monitoring and Technology Services
Division (former)(8)
|
|
|
2007
|
|
|
|
260,000
|
|
|
|
20,000
|
|
|
|
66,508
|
|
|
|
|
|
|
|
|
|
|
|
6,843
|
|
|
|
84,102
|
|
|
|
437,453
|
|
|
|
|
(1)
|
|
Amounts shown in All Other Compensation include the
following:
|
|
|
|
Mr. Saper:
auto
allowance, $54,877 in 2008, $53,539 in 2007; auto maintenance,
$18,294 in 2008, $18,414 in 2007; personal commuting expenses,
$10,000 in 2008, $10,000 in 2007; payment of personal tax and
estate planning services, $0 in 2008, $36,970 in 2007; annual
club dues and imputed interest on loan for club membership,
$21,262 in 2008, $21,262 in 2007; reimbursement for executive
portion of split-dollar life insurance, $164,820 in 2008,
$135,000 in 2007; tax
gross-ups,
$189,894 in 2008, $180,563 in 2007; 401(k) Plan matching
contribution, $6,900 in 2008, $7,584 in 2007; company paid
premiums for term-life insurance and long-term disability
insurance, $877 in 2008, $877 in 2007; and executive medical
plan reimbursements, $47,581 in 2008, $38,945 in 2007.
|
|
|
|
|
|
|
|
Mr. Laudani:
payments
for auto, $74,800 in 2008, $58,513 in 2007; premium for
executive medical plan $2,295 in 2008, $2,444 in 2007, payments
for rent and utilities for an apartment used by Mr. Laudani
while he is in the United States of $33,340 in 2008. All other
benefits for Mr. Laudani are covered under the Italian
governments statutory benefit plans.
|
|
|
|
Mr. Scaramelli:
personal
auto, $6,065 in 2008, $4,660 in 2007; tax
gross-up,
$3,998 in 2008, $3,072 in 2007; 401(k) Plan matching
contribution, $10,625 in 2008, $6,600 in 2007; company paid
premiums for term-life insurance and long-term disability
insurance, $1,016 in 2008, $1,016 in 2007; and executive medical
plan reimbursements, $1,226 in 2008, $1,668 in 2007.
|
|
|
|
Mr. Krauskopf:
personal
auto, $4,999 in 2008, $4,048 in 2007; tax
gross-up,
$13,182 in 2008, $28,087 in 2007; 401(k) Plan matching
contribution, $9,208 in 2008, $2,750 in 2007; company paid
premiums for term-life insurance and long-term disability
insurance, $1,016 in 2008, $1,016 in 2007; executive medical
plan reimbursements, $4,848 in 2008, $9,464 in 2007 and personal
living and relocation expenses, $15,591 in 2008, $40,085 in 2007.
|
|
|
|
|
18
|
|
|
|
|
Mr. Leschinsky:
personal
auto, $10,586 in 2008, $10,580 in 2007; tax
gross-up,
$23,718 in 2008, $24,733 in 2007; 401(k) Plan matching
contribution, $8,163 in 2008, $6,825 in 2007; company paid
premiums for term-life insurance and long-term disability
insurance, $1,016 in 2008, $1,016 in 2007; relocation loan and
interest forgiveness $26,400 in 2008, $28,000 in 2007; and
executive medical plan reimbursements, $11,650 in 2008, $14,309
in 2007.
|
|
|
|
|
|
|
|
Mr. Gibson:
personal
auto, $456 in 2008, $4,500 in 2007; tax
gross-up,
$24,772 in 2008, $26,404 in 2007; 401(k) Plan matching
contribution, $9,176 in 2008, $6,600 in 2007; company paid
premiums for term-life insurance and long-term disability
insurance, $883 in 2008, $1,016 in 2007; executive medical plan
reimbursements, $10,072 in 2008, $8,621 in 2007; and
reimbursement of personal living and relocation expenses,
$38,591 in 2008, $36,961 in 2007.
|
|
(2)
|
|
The net change in post-employment benefit values in Fiscal 2008
and Fiscal 2007, respectively, for Mr. Saper is comprised
of the following:
|
|
|
|
|
|
|
|
Datascope Corp. Pension Plan $130,134 and $18,549
SERP $340,779 and $1,058,476
Post-Retirement Medical Plan $21,325 and $27,694
|
|
(3)
|
|
Mr. Laudani is an Italian citizen and his compensation is
paid in Euros. Dollar amounts in this Information Statement with
respect to Mr. Laudani have been calculated using an
average exchange rate of 1 Euro to 1.461320 and 1.308311 U.S.
dollars in Fiscal 2008 and Fiscal 2007, respectively.
|
|
|
|
|
|
(4)
|
|
Includes discretionary bonus of $189,240 paid in Fiscal 2008
related to the sale of the Patient Monitoring business, $52,608
bonus paid in Fiscal 2008 pursuant to the Fiscal 2007 bonus plan
for EMEA and $250,000 earned in Fiscal 2008 under the Executive
Bonus Plan.
|
|
(5)
|
|
Includes discretionary bonus of $104,665 earned in Fiscal 2007
under the Executive Bonus Plan and $78,500 bonus earned pursuant
to the Fiscal 2007 bonus plan for EMEA.
|
|
(6)
|
|
Includes discretionary bonus of $91,000 paid in Fiscal 2008
related to the sale of the Patient Monitoring business and
$85,000 earned in Fiscal 2008 under the Executive Bonus Plan.
|
|
(7)
|
|
Includes a sign-on bonus of $25,000 paid in Fiscal 2007.
Mr. Krauskopf began his employment with Datascope in
February 2006.
|
|
(8)
|
|
Mr. Gibsons employment with Datascope terminated on
May 1, 2008, the effective date of the sale of the Patient
Monitoring business.
|
|
(9)
|
|
Consists of discretionary closing bonus paid in Fiscal 2008
related to the sale of the Patient Monitoring business.
|
GRANTS
OF PLAN-BASED AWARDS
The following table provides information regarding option awards
to the Named Executive Officers during fiscal year 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Awards:
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
Estimated Future Payouts
|
|
|
Estimated Future Payouts
|
|
|
Number of
|
|
|
Number of
|
|
|
Exercise or
|
|
|
Date Fair
|
|
|
|
|
|
|
Under Non-Equity Incentive
|
|
|
Under Equity Incentive
|
|
|
Shares of
|
|
|
Securities
|
|
|
Base Price
|
|
|
Value of
|
|
|
|
|
|
|
Plan Awards
|
|
|
Plan Awards
|
|
|
Stock or
|
|
|
Underlying
|
|
|
of Option
|
|
|
Stock and
|
|
|
|
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Units
|
|
|
Options
|
|
|
Awards
|
|
|
Option
|
|
Name
|
|
Grant Date
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)
|
|
|
(#)
|
|
|
($/Sh)
|
|
|
Awards
|
|
|
Lawrence Saper
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonino Laudani
|
|
|
8/22/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
(1)
|
|
|
|
|
|
|
973,200
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
8/22/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
(1)
|
|
|
|
|
|
|
324,400
|
|
|
|
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Boris Leschinsky
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
David A. Gibson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
The restricted stock vests in four equal annual installments of
25% on the anniversary of the grant date.
|
19
OUTSTANDING
EQUITY AWARDS AT FISCAL YEAR-END
The following table provides information regarding the equity
awards held by the Named Executive Officers that are outstanding
as of June 30, 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Market or
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Unearned
|
|
|
Payout
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
Shares,
|
|
|
Value of
|
|
|
|
Number of
|
|
|
Securities
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Shares or
|
|
|
Shares or
|
|
|
Units or
|
|
|
Unearned
|
|
|
|
Securities
|
|
|
Underlying
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
Units of
|
|
|
Units of
|
|
|
Other
|
|
|
Shares, Units or
|
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Option
|
|
|
|
|
|
Stock That
|
|
|
Stock That
|
|
|
Rights
|
|
|
Other Rights
|
|
|
|
Unexercised
|
|
|
Options
|
|
|
Unearned
|
|
|
Exercise
|
|
|
Option
|
|
|
Have Not
|
|
|
Have Not
|
|
|
That Have
|
|
|
That Have
|
|
|
|
Options (#)
|
|
|
(#)
|
|
|
Options
|
|
|
Price
|
|
|
Expiration
|
|
|
Vested
|
|
|
Vested
|
|
|
Not Vested
|
|
|
Not Vested
|
|
Name
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
(#)
|
|
|
($)
|
|
|
Date
|
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Lawrence Saper
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
|
|
28.665
|
|
|
|
2/18/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonino Laudani
|
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
|
28.87
|
|
|
|
6/2/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,900
|
|
|
|
|
|
|
|
|
|
|
|
28.80
|
|
|
|
5/19/13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,500
|
|
|
|
|
|
|
|
|
|
|
|
32.86
|
|
|
|
5/17/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
38.145
|
(1)
|
|
|
2/14/15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
28.525
|
(2)
|
|
|
5/16/15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
1,410,000
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
3,500
|
|
|
|
|
|
|
|
|
|
|
|
37.032
|
|
|
|
5/15/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,000
|
|
|
|
|
|
|
|
|
|
|
|
39.45
|
|
|
|
5/14/11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,200
|
|
|
|
|
|
|
|
|
|
|
|
30.275
|
|
|
|
5/15/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,500
|
|
|
|
|
|
|
|
|
|
|
|
32.765
|
(3)
|
|
|
9/22/13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,500
|
|
|
|
|
|
|
|
|
|
|
|
32.86
|
|
|
|
5/17/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
470,000
|
|
|
|
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
|
|
|
|
38.415
|
(4)
|
|
|
2/22/16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Boris Leschinsky
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
26.938
|
|
|
|
5/25/09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
28.80
|
|
|
|
5/19/13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
30.275
|
|
|
|
5/15/12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
600
|
|
|
|
|
|
|
|
|
|
|
|
32.86
|
|
|
|
5/17/14
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,250
|
|
|
|
3,750
|
|
|
|
|
|
|
|
35.235
|
(5)
|
|
|
7/25/15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
37.032
|
|
|
|
5/15/10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000
|
|
|
|
|
|
|
|
|
|
|
|
39.45
|
|
|
|
5/14/11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
David A. Gibson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Prior to the fifth anniversary of the grant date, the option is
exercisable only if the average of the high and low sale prices
of Datascopes Common Stock as quoted on the NASDAQ Global
Select Market on the trading day immediately preceding the
exercise date is equal to or greater than $43.00 (the
threshold price
). After the fifth anniversary
of the grant date, the option is fully exercisable, without any
regard to the price of the Common Stock.
|
|
(2)
|
|
Same provision as (1) above with a threshold price of
$38.525.
|
|
|
|
|
|
(3)
|
|
Same provision as (1) above with a threshold price of
$38.00.
|
|
(4)
|
|
Same provision as (1) above with a threshold price of
$43.50.
|
|
(5)
|
|
Same provision as (1) above with a threshold price of
$40.25.
|
20
OPTION
EXERCISES AND STOCK VESTED
The following table provides additional information regarding
the value realized by the Named Executive Officers on option
award exercises and stock award vesting during the Fiscal 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of Shares
|
|
|
Value
|
|
|
Number of Shares
|
|
|
Value
|
|
|
|
Acquired on
|
|
|
Realized on
|
|
|
Acquired on
|
|
|
Realized on
|
|
|
|
Exercise
|
|
|
Exercise
|
|
|
Vesting
|
|
|
Vesting
|
|
Name
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Lawrence Saper
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Antonino Laudani
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Boris Leschinsky
|
|
|
10,000
|
|
|
|
109,260
|
|
|
|
|
|
|
|
|
|
David A. Gibson
|
|
|
64,000
|
|
|
|
333,414
|
|
|
|
|
|
|
|
|
|
PENSION
BENEFITS
The following table summarizes pension benefits of the Named
Executive Officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments
|
|
|
|
Number of
|
|
|
Present Value of
|
|
|
During
|
|
|
|
Years
|
|
|
Accumulated
|
|
|
Last Fiscal
|
|
|
|
Credited
|
|
|
Benefit
|
|
|
Year
|
|
Name
|
|
Service (#)
|
|
|
($)
|
|
|
($)
|
|
|
Datascope Corp. Pension Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Saper
|
|
|
44.00
|
|
|
|
1,177,502
|
|
|
|
103,839
|
|
Antonino Laudani(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
Henry M. Scaramelli
|
|
|
17.50
|
|
|
|
244,716
|
|
|
|
|
|
Timothy J. Krauskopf
|
|
|
2.42
|
|
|
|
19,706
|
|
|
|
|
|
Boris Leschinsky
|
|
|
17.50
|
|
|
|
91,757
|
|
|
|
|
|
David A. Gibson
|
|
|
5.00
|
|
|
|
23,529
|
|
|
|
|
|
SERP
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Saper
|
|
|
44.00
|
|
|
|
16,999,814
|
|
|
|
|
|
Post Retirement Medical
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence Saper
|
|
|
44.00
|
|
|
|
229,129
|
|
|
|
|
|
|
|
|
(1)
|
|
Mr. Laudanis pension benefits are covered under the
Italian governments pension program.
|
Potential
Payments Upon Termination or
Change-in-Control
Each of Datascopes executive officers, other than
Mr. Saper, is currently a party to an agreement with
Datascope which, in general, provides that if such executive
officers employment is terminated in connection with a
change-in-control
of Datascope, such officer may be entitled to receive severance
payments and other benefits. Mr. Saper is party to an
employment agreement with Datascope that may entitle
Mr. Saper to payments and other benefits in the event of
the termination of his employment. The material provisions of
these agreements that relate to potential payments in connection
with a
change-in-control
of Datascope, including the approximate amount of such payments,
are described in detail below. For purposes of determining the
potential payments, January 31, 2009 was used as the
hypothetical date upon which the
change-in-control
event occurs; however the actual date could be earlier or later,
which would affect the amount of payments to be made.
January 31, 2009 was used instead of June 30, 2008
(the end of Datascopes fiscal year) because the
approximate amount of payments to be made in the event of a
change-in-control
as of January 31, 2009, is a more accurate reflection of
Datascopes costs in light of the Offer and proposed Merger.
21
Lawrence Saper
.
Datascope and
Mr. Saper executed an employment agreement on July 1,
1996, which has subsequently been amended. The term of
Mr. Sapers employment is for a period of five years
and automatically renews each day for an additional day so there
is always five years remaining in his employment term. This
agreement may entitle Mr. Saper to payment, if Datascope
terminates Mr. Sapers employment without
cause (as defined in his employment agreement) or if
Mr. Saper terminates his employment for good
reason (as defined in his employment agreement). The
consummation of this Offer will constitute good
reason under the agreement. Upon such a termination,
Mr. Saper may be entitled to receive his bonus compensation
accrued through the date of termination and a lump-sum cash
payment equal to the present value of the product of
(i) the sum of the weighted average for the three years
prior to such termination of (A) his annual base salary
over such three-year period and (B) all bonus compensation
paid or payable to him over such three-year period, multiplied
by (ii) five. If Mr. Sapers employment is
terminated by Datascope without cause or by
Mr. Saper for good reason on January 31,
2009, then this payment will equal approximately $5,747,118.
Upon such a termination of employment, Mr. Saper is also
entitled to receive the retirement benefits described below.
In addition to the payments described related to certain
termination events in the preceding paragraph, upon any
termination without cause, including retirement,
Mr. Saper is entitled to receive compensation for all
benefits which he would have received under Datascopes
employee benefit plans for the full five year remaining term of
employment. If Mr. Sapers employment is terminated by
Datascope in breach of his employment agreement on
January 31, 2009, Mr. Saper will receive approximately
$765,523 in connection with the payments described in this
paragraph.
Following any termination of his employment, Mr. Saper and
his spouse at the time of such termination will also receive
reimbursement for all medical expenses incurred by them during
their lifetime that are not covered by Medicare. If
Mr. Sapers employment is terminated on
January 31, 2009, the actuarial present value of the
benefits described in this paragraph will be approximately
$229,129.
In addition to the benefits described in the preceding
paragraphs, upon Mr. Sapers termination of
employment, Mr. Saper will receive, on a monthly basis for
the remainder of his life, the greater of (1) the
retirement benefit (as defined in his employment
agreement) payable under the supplemental executive retirement
program (excluding all benefits payable under Datascopes
qualified pension plan) and (2) the minimum
retirement benefit (as defined in his employment
agreement). If Mr. Sapers employment is terminated on
January 31, 2009, the actuarial present value of this
benefit will be approximately $17,318,387. In addition, in the
event of Mr. Sapers death, a trust created for the
benefit of Mr. Sapers spouse and children will
receive $10,000,000 pursuant to a split dollar agreement between
Mr. Saper, Datascope and the trust. In addition, Datascope
will, for a period of five years after a termination of
Mr. Sapers employment in breach of his employment
agreement, reimburse Mr. Saper for a portion of the
premiums under such split dollar agreement, as well as taxes
incurred by Mr. Saper in connection with such split dollar
agreement. If Mr. Sapers employment is terminated on
January 31, 2009, the actuarial present value of these
benefits will be approximately $3,575,377.
Upon the Effective Time, Mr. Saper will also be entitled to
receive a payment in exchange for the cancellation of his then
outstanding options, as set forth in the table on page 24.
Other Executive Officers
.
Datascope has
entered into an executive severance agreement with certain
executive officers of Datascope including each of
Messrs. Adelman, Barker, Cathcart, Krauskopf, Laudani,
Leschinsky and Scaramelli. Each of these agreements have
substantially similar terms and provide that, if any such
executive officers employment is terminated within two
years following the occurrence of a
change-in-control
(as defined in the severance agreement), either by Datascope
without cause (as defined in the severance
agreement) or by the executive officer following an event
constituting a constructive dismissal (as defined in
the severance agreement), then such executive officer may be
entitled to receive, in a lump-sum cash payment within thirty
days after such termination, the following: (I) a payment
equal to the product of (A) 2.99 and (B) the sum of
(i) the executives base salary then in effect and
(ii) the greater of (a) the amount of the bonus
payable to the executive for the fiscal year preceding the
fiscal year in which the notice of termination (as
defined in the severance agreement) is provided or (b) the
average of the bonuses
22
payable to the executive in each of the three fiscal years (or
such shorter number of fiscal years during which the executive
was employed) preceding the fiscal year in which the
notice of termination was provided, (II) a
pro-rated bonus based on the number of days elapsed in the
fiscal year of termination, assuming 100% of the targeted
performance under any relevant performance metric, and
(III) the value of any long-term performance plan awards at
the end of the month preceding termination on the basis of an
equitable pro-rating of the performance period, performance
targets and award amount. The payments described in the
preceding sentence are referred to herein as the Severance
Payments. The consummation of the Offer is expected to
constitute a
change-in-control
under each of the executive severance agreements. The
approximate value of the Severance Payments that each executive
could receive upon a termination of employment following the
Offer is set forth in the table below.
Following a termination of employment described in the preceding
paragraph and for a period of two years thereafter, each such
executive officer (and his dependents) may be entitled to
receive (a) medical and health benefits at the levels of
such benefits in effect prior to such termination and (b) a
monthly payment equal to the economic value of the pension,
retirement, life insurance, accident, disability, welfare,
savings, and compensation benefits at the levels of such
benefits in effect prior to such termination. The benefits
described in this paragraph are referred to herein as the
Plan Benefits. The approximate value of the Plan
Benefits that each executive could receive upon a termination of
employment following the Offer is set forth in the table below.
Additionally, under the terms of each executive severance
agreement, if an executive would be subject to the excise tax
imposed under Section 4999 of the Code, then Datascope will
reduce the total payments (collectively, the
Parachute
Payments
) to such executive by the amount necessary to
make such payments $1.00 below the safe harbor amount under
Section 280G of the Code, but only if the total Parachute
Payments exceed the safe harbor by less than $100,000. However,
if the total Parachute Payments exceed the safe harbor by at
least $100,000, then Datascope will pay to the executive an
amount such that the executive will be in the same position as
if no excise taxes under Section 4999 of the Code had been
imposed. The payment described in the preceding sentence is
referred to herein as the
Gross-Up Payment
.
The approximate value of the
Gross-Up
Payment that each executive could receive upon a termination of
employment following the Offer is set forth in the table below.
In addition to the payments described above, certain of the
executive officers may receive additional payments in connection
with the Offer. Mr. Leschinsky previously received a
relocation loan from Datascope, the repayment of which may be
forgiven in the event of his termination of employment.
Additionally, Messrs. Scaramelli and Leschinsky are parties
to restrictive covenant agreements which provide that the
executive will not solicit Datascope employees or compete
against Datascope during the one-year period following such
executives termination of employment. During this
restrictive covenant period, Datascope will provide the
executive with one year of base salary continuation, provided
such executive does not violate the non-compete or
non-solicitation or other provisions of the restrictive covenant
agreement. Any payments under these agreements will be paid in
accordance with Datascopes normal payroll practices and
such payments may be terminated if the executive obtains
employment during the restrictive covenant period. The
approximate value of these payments (calculated without
reference to any potential offset) is set forth in the table
below.
23
The following table sets forth the approximate value of the
payments that Messrs. Adelman, Barker, Cathcart, Krauskopf,
Laudani, Leschinsky and Scaramelli could receive assuming the
Offer is consummated (and constitutes a
change-in-control
under their severance agreements) and their employment is
terminated either without cause or as the result of
a constructive dismissal on January 31, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance
|
|
|
Plan
|
|
|
Gross Up
|
|
|
Non-Compete
|
|
|
Tax
|
|
|
Total
|
|
Executive
|
|
Payments
|
|
|
Benefits
|
|
|
Payments
|
|
|
Payments
|
|
|
Reimbursements
|
|
|
Payments
|
|
|
Fred Adelman
|
|
$
|
1,178,680
|
|
|
$
|
58,488
|
|
|
$
|
535,081
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,772,249
|
|
Nicholas Barker
|
|
$
|
1,122,657
|
|
|
$
|
80,852
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,203,509
|
|
Robert Cathcart
|
|
$
|
1,170,422
|
|
|
$
|
92,810
|
|
|
$
|
530,050
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,793,282
|
|
Antonino Laudani
|
|
$
|
3,407,156
|
|
|
$
|
36,321
|
|
|
$
|
834,228
|
|
|
$
|
0
|
|
|
|
*
|
|
|
$
|
4,277,705
|
**
|
Boris Leschinsky
|
|
$
|
1,056,119
|
|
|
$
|
75,786
|
|
|
$
|
600,459
|
|
|
$
|
230,000
|
|
|
$
|
0
|
|
|
$
|
1,962,364
|
|
Timothy Krauskopf
|
|
$
|
1,122,882
|
|
|
$
|
84,603
|
|
|
$
|
531,333
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,738,818
|
|
Henry Scaramelli
|
|
$
|
1,496,057
|
|
|
$
|
84,268
|
|
|
$
|
894,899
|
|
|
$
|
260,000
|
|
|
$
|
0
|
|
|
$
|
2,735,224
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Payments
|
|
$
|
10,553,973
|
|
|
$
|
513,128
|
|
|
$
|
3,926,050
|
|
|
$
|
490,000
|
|
|
$
|
0
|
|
|
$
|
15,483,151
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
|
Due to his relocation to the United States in October 2007,
Mr. Laudani may be subject to duplicate taxation in the
United States and Italy for income received from Datascope since
October 2007. Datascope may pay, on Mr. Laudanis
behalf, any taxes assessed in the United States for income to
Mr. Laudani from Datascope since October 2007.
|
|
**
|
|
Excludes the effect of any taxes which may be paid by Datascope
on Mr. Laudanis behalf.
|
In addition to the payments described above, at the effective
time of the Meger (i.e. upon the termination of the Merger),
each outstanding and unvested option held by each executive will
vest in full and will be cancelled in exchange for a payment
equal to the product of (1) the excess, if any, of the
Offer Price over the exercise price per share of such option,
multiplied by (2) the total number of shares of Common
Stock underlying such option. Each share of restricted stock
held by the executive will vest in full and become free from any
forfeiture restrictions at the effective time of the Merger. The
approximate value of the cash payments that each executive will
receive in exchange for the cancellation of such options
(assuming that each such officer does not otherwise exercise any
outstanding and vested Options prior to the consummation of the
Offer) and the removal of forfeiture restrictions on shares of
restricted stock is set forth in the table below. This
information is based on the officers options and
restricted stock ownership as of September 12, 2008 and
such amounts are pre-tax amounts.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of
|
|
|
|
|
|
|
Options
|
|
|
Restricted Stock
|
|
|
Total Equity
|
|
Executive
|
|
Outstanding
|
|
|
Outstanding
|
|
|
Payments
|
|
|
Lawrence Saper
|
|
|
500,000
|
|
|
|
0
|
|
|
$
|
12,167,500
|
|
Fred Adelman
|
|
|
21,700
|
|
|
|
0
|
|
|
$
|
413,064
|
|
Nicholas Barker
|
|
|
45,000
|
|
|
|
0
|
|
|
$
|
794,518
|
|
Robert Cathcart
|
|
|
54,000
|
|
|
|
0
|
|
|
$
|
890,460
|
|
Timothy Krauskopf
|
|
|
20,000
|
|
|
|
0
|
|
|
$
|
291,700
|
|
Antonino Laudani
|
|
|
40,400
|
|
|
|
22,500
|
|
|
$
|
1,979,590
|
|
Boris Leschinsky
|
|
|
25,600
|
|
|
|
0
|
|
|
$
|
483,569
|
|
Henry Scaramelli
|
|
|
19,700
|
|
|
|
7,500
|
|
|
$
|
759,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Payments
|
|
|
|
|
|
|
|
|
|
$
|
17,780,097
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grantor Trust
.
Under the terms of the
Grantor Trust Agreement, dated as of September 4, 2001, by
and between Datascope and Wachovia Bank, N.A., and certain other
related agreements between Datascope and the executive officers,
certain of the amounts described above were required to be
funded and contributed to the Grantor Trust within thirty days
after the occurrence of a potential
change-in-control
and
change-in-control
(as both terms are defined in the Grantor Trust Agreement).
No additional compensation
24
or benefits are provided to the executive officers under the
Grantor Trust. Amounts contributed to the Grantor Trust are
merely used to satisfy certain amounts due to the executive
officers (and certain other current and former employees), which
were contingent upon the
change-in-control
and/or
the
termination of such individuals employment with Datascope.
The approval by the Board and the execution of the Merger
Agreement constituted a potential
change-in-control;
accordingly within thirty days after the execution of the Merger
Agreement, Datascope was required to contribute to the Grantor
Trust an amount equal to the total payments the executive
officers (and certain other current and former employees) could
have been entitled to receive, assuming that the
change-in-control
event (and other events upon which payment of such amount was
contingent) had occurred on the first business day of the
calendar year. Accordingly, Datascope contributed $45,182,103 to
the Grantor Trust on October 15, 2008. Under the terms of
the Grantor Trust Agreement, after the occurrence of a
change-in-control,
such as the consummation of the Offer, the funding of the
Grantor Trust must be recalculated annually to ensure sufficient
funding is available to provide any required, remaining
change-in-control
or termination benefits or payments left to be provided to the
executive officers.
Loan to Officer
.
On June 9, 2000,
Boris Leschinsky, Vice President of Technology, received a loan
from Datascope with a principal amount of $200,000. The
promissory note requires annual payments of $20,000 plus
interest, based on an annual rate of 8% with the final payment
due on June 8, 2010. The current principal balance is
$40,000. The largest aggregated amount outstanding at any time
during the fiscal year ended June 30, 2008 was $64,800 and
the amount outstanding as of September 12, 2008 was
$40,833. In the event that Mr. Leschinskys employment
is terminated due to a change of control of Datascope occurring
before June 9, 2010, then the balance of the note will be
forgiven.
NON-EMPLOYEE
DIRECTOR COMPENSATION
Datascopes current non-employee director compensation
program became effective on July 1, 2006. Effective
January 1, 2007, the annual retainer for each non-employee
director of Datascope was increased to $25,000. Payment of the
annual retainer occurs at the beginning of the next succeeding
calendar year. A director may elect to receive deferred stock
units or restricted stock pursuant to the 2005 Equity Incentive
Plan in lieu of the annual cash retainer;
provided
,
however
, that pursuant to the Merger Agreement, Datascope
agreed not to issue any additional deferred stock units or
restricted stock pending consummation of the Offer and the
Merger. The first awards pursuant to such elections were granted
on January 1, 2007 in lieu of annual retainer fees for the
2007 calendar year. If elected, deferred stock units vest
pro-rata over the twelve-month period following the grant date,
becoming fully vested on the first anniversary of the grant
date, and are paid either on the first business day on or after
an anniversary of the grant date or on the first business day of
the calendar year following the directors termination of
service as a director, at the election of the director.
Restricted stock vests in monthly installments over the
twelve-month period following the grant date, becoming fully
vested on the first anniversary of the grant date.
Beginning January 1, 2007, each director (except
Mr. Saper) also receives restricted shares worth $70,000,
with one-year vesting restrictions, pursuant to the 2005 Equity
Incentive Plan. A director may elect to defer receipt of
compensation, in which case the award will be paid entirely in
restricted stock units.
In addition to the annual retainer described above, the chairman
of the Audit Committee receives an annual retainer of $10,000,
each chairman of the Compensation Committee and the Nominating
Committee receives an annual retainer of $7,500 and each member
(other than the chairman) of the Audit Committee, Compensation
Committee and Nominating Committee receives an annual retainer
of $3,000. Each non-employee director of Datascope also receives
a fee of $2,000 for each meeting of the Datascope Board which
such director attended in person, $1,000 for each meeting of the
Datascope Board for each telephonic meeting of the Datascope
Board, $1,000 for each committee meeting which such director
attended in person and $500 for each telephonic committee
meeting. In Fiscal 2008, Mr. Loughlin was named as Lead
Director and was granted an additional $15,000 per year
compensation for his service in that role.
From time to time, Datascope has granted options to directors to
purchase shares of Common Stock. These options remain
exercisable in full until the earlier of ten years after the
date of grant or the termination of status as a director of
Datascope, and are not transferable except that each of the
options may be exercised
25
by an executor or administrator within one year after an
optionees death or disability but not beyond the
options normal expiration date. Each option provides that
the optionee may pay for any shares acquired pursuant to the
exercise of such option by cash or check or by transfer to
Datascope of a number of shares of Common Stock with an
aggregate market value equal to the aggregate option exercise
price. Such options do not qualify as incentive stock options
under the Code. For federal income tax purposes, an optionee
will realize taxable income on the date of exercise of an
option, and Datascope will then be allowed a deduction from
income, equal to the excess of (a) the aggregate market
value, on the date of exercise, of the shares so acquired over
(b) the aggregate option exercise price for such shares.
Transactions with respect to stock options granted to directors
who are officers of Datascope pursuant to the 1981 Stock Option
Plan, the 1995 Stock Option Plan, the 2005 Equity Incentive Plan
and with respect to certain director options which have been
approved by the stockholders of Datascope are exempt from the
short-swing trading liability provisions of Section 16(b)
of the Exchange Act, pursuant to
Rule 16b-3
of the Exchange Act. The 1981 Stock Option Plan and the 1995
Stock Option Plan do not cover grants to directors who are not
employees or officers of Datascope. The Datascope Corp. 2005
Equity Incentive Plan covers grants to directors who are not
employees or officers of Datascope.
Mr. Altschiller has been engaged as a consultant to
Datascope since September 1998, providing advice and counsel in
the area of advertising. In consideration for these services,
Datascope paid Mr. Altschiller a consulting fee of $200,000
during Fiscal 2008.
2008 Director
Compensation Table
The following table shows compensation for Fiscal 2008 for our
non-employee directors.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
Fees
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
Earned or
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
Paid in
|
|
|
Stock
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
|
|
Cash
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Alan B. Abramson
|
|
|
53,000
|
|
|
|
82,530
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
135,530
|
|
David Altschiller
|
|
|
17,000
|
|
|
|
95,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,288
|
(1)
|
|
|
312,326
|
|
William L. Asmundson(2)
|
|
|
19,000
|
|
|
|
47,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66,596
|
|
David Dantzker, M.D.(3)
|
|
|
15,000
|
|
|
|
12,439
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,439
|
|
Robert E. Klatell
|
|
|
51,500
|
|
|
|
95,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
146,538
|
|
James J. Loughlin
|
|
|
56,000
|
|
|
|
95,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
151,038
|
|
William W. Wyman
|
|
|
55,000
|
|
|
|
82,538
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
137,530
|
|
|
|
|
(1)
|
|
Of the $200,288 set forth in the table, $288 represents the cash
portion of a deferred share distribution and $200,000 represents
the amount paid to Mr. Altschiller as a consultant to
Datascope for advice and counsel in the area of advertising in
Fiscal 2008.
|
|
(2)
|
|
Mr. Asmundson left the Datascope Board on January 3,
2008, and was a director for only a portion of Fiscal 2008.
|
|
(3)
|
|
Dr. Dantzker joined the Datascope Board on January 3,
2008, and was a director for only a part of Fiscal 2008.
|
26
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
Transactions
with Related Persons
Adam Saper, the son of Lawrence Saper, Chairman of the Board of
Directors and CEO, was employed by Datascope and held the title
of Director of Business Development, Patient Monitoring
Division, until the termination of his employment from Datascope
on June 30, 2008. During Fiscal 2008, Datascope paid Adam
Saper $171,018 in base salary. He was not awarded a bonus in
Fiscal 2008. Pursuant to an Agreement and Release between
Datascope and Adam Saper, he will receive severance payments for
13 weeks totaling $43,139.
On June 9, 2000, Boris Leschinsky, Vice President of
Technology, received a loan from Datascope with a principal
amount of $200,000. The promissory note requires annual payments
of $20,000 plus interest, based on an annual rate of 8% with the
final payment due on June 8, 2010. The current principal
balance is $40,000. The largest aggregated amount outstanding at
any time during Fiscal 2008 was $64,800 and the amount
outstanding as of September 12, 2008 was $40,833. In the
event that Mr. Leschinskys employment is terminated
due to a change of control of Datascope occurring before
June 9, 2010, then the balance of the note will be forgiven.
See Non-Employee Director Compensation
for
disclosure of compensation payable to Mr. Altschiller.
Review of
Transactions with Related Persons
The Audit Committee of the Datascope Board reviews and approves
all transactions with related parties, including
(i) transactions involving potential conflicts of interest
with corporate officers and directors, (ii) transactions
involving any immediate family members of any corporate officers
and directors and (iii) any other related party
transactions. This responsibility of the Audit Committee is set
forth in writing in the charter of the Audit Committee. Based
upon its consideration of all relevant facts and circumstances,
the Audit Committee determines whether such transaction is in
the best interests of Datascope and whether or not to approve
such transaction. The Compensation Committee of the Datascope
Board reviews and approves all compensation-related matters
regarding Adam Saper.
27
REPORT
OF THE AUDIT COMMITTEE
The Audit Committee is comprised of David R.
Dantzker, M.D., Robert E. Klatell, James J. Loughlin and
William W. Wyman. Mr. Loughlin serves as Chairperson of the
Audit Committee. Each of the members of the audit committee is
independent as defined under applicable National
Association of Securities Dealers, Inc.s listing standards
and is financially literate as that qualification is interpreted
by the Datascope Board. In addition, at least one member of the
Audit Committee has accounting or related financial management
experience, as the Datascope Board interprets that
qualification. The Datascope Board has adopted a written charter
with respect to the Audit Committees roles and
responsibilities.
The Audit Committees primary duties and responsibilities
are to (1) monitor the integrity of Datascopes
financial reporting process and systems of internal controls
regarding finance, accounting, and legal compliance,
(2) monitor the independence and performance of
Datascopes independent registered public accounting firm
and (3) provide an avenue of communication among the
independent registered public accounting firm, management, and
the Datascope Board.
It is the responsibility of the independent registered public
accounting firm to audit Datascopes consolidated financial
statements. The Audit Committee does not provide any expert or
other special assurance as to Datascopes financial
statements or any expert or professional certification as to the
work of Datascopes independent registered public
accounting firm. The Audit Committee has the sole authority to
appoint or replace the independent registered public accounting
firm.
In fulfilling its oversight responsibilities, the Audit
Committee reviewed and discussed Datascopes audited
financial statements with its management and
Deloitte & Touche LLP, its independent registered
public accounting firm. The Audit Committee also discussed with
Deloitte & Touche LLP the matters required to be
discussed by Statement on Auditing Standards No. 61
(Communications with Audit Committees) as amended by Statement
on Auditing Standards No. 90 (Audit Committee
Communications) and as adopted by the Public Company Accounting
Oversight Board (United States) (PCAOB). This
included a discussion of the independent registered public
accounting firms judgments as to the quality, not just the
acceptability, of Datascopes accounting principles, and
such other matters that PCAOB standards require to be discussed
with the Audit Committee. The Audit Committee also received the
written disclosures and the letter from Deloitte &
Touche LLP required by Independence Standards Board Standard
No. 1 (Independence Discussion with Audit Committee), as
adopted by the PCAOB, and the Audit Committee discussed the
independence of Deloitte & Touche LLP with that firm.
Based on the Audit Committees review and discussions noted
above, the Audit Committee recommended to the Datascope Board,
and the Datascope Board approved, the audited financial
statements to be included in Datascopes Annual Report on
Form 10-K
for the fiscal year ended June 30, 2008 for filing with the
Securities and Exchange Commission.
Audit Committee
David R. Dantzker, M.D.
Robert E. Klatell
James J. Loughlin, Chairperson
William W. Wyman
28
COMPANY
STOCK PERFORMANCE
The following graph compares the cumulative total stockholder
return on Common Stock with the cumulative total return of the
Standard & Poors 500 Stock Index and the
Standard & Poors Health Care Equipment Index for
the five year period commencing July 1, 2003 and each
subsequent June 30 through June 30, 2008. The graph assumes
that the value of the investment in Common Stock was $100 on
July 1, 2003 and that all dividends were reinvested.
COMPARISON
OF 5 YEAR CUMULATIVE TOTAL RETURN
SECTION 16(A)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires Datascopes
directors and executive officers and persons who beneficially
own more than 10% of a registered class of Datascopes
equity securities (
Reporting Persons
) to file
reports of ownership and changes in ownership with the
Securities and Exchange Commission on a timely basis. Reporting
Persons are required to furnish Datascope with copies of all
such forms that they file. Based solely on its review of such
forms, Datascope believes that all filing requirements
applicable to Reporting Persons during and with respect to
fiscal year 2008 were complied with on a timely basis other than
as follows: (i) on September 11, 2007, Antonino
Laudani filed a late Form 4 reporting the grant of 30,000
restricted stock shares on August 22, 2007; (ii) on
September 11, 2007, Henry Saramelli filed a late
Form 4 reporting the grant of 10,000 restricted stock
shares on August 22, 2007; (iii) on January 9,
2008, David Dantzker filed a late Form 4 reporting the
receipt of 689 deferred shares that were granted on
January 3, 2008; and (iv) on September 18, 2008,
Timothy Krauskopf filed a late Form 4 reporting the
issuance, on August 4, 2007, of 214 shares of Common
Stock in his 401(k) plan and the subsequent sale, on
October 4, 2007, of 220 shares of Common Stock.
29
SCHEDULE A
DIRECTORS
AND EXECUTIVE OFFICERS OF PURCHASER
The following table sets forth the name, age, present principal
occupation or employment and material occupations, positions,
offices or employment for the past five years of the directors
and executive officers of Purchaser whom Purchaser has
identified as the candidates to be Purchasers Designees.
Unless otherwise indicated below, (1) each individual has
held his positions for more than the past five years and
(2) the business address of each person is DaVinci Merger
Sub, Inc.
c/o Getinge
AB Ekebergsvagen 26, Getinge, Sweden SE-310 44. In the event
that additional Purchasers Designees are required in order
to constitute a majority of the Datascope Board, such additional
Purchasers Designees will be selected by Purchaser from
among the directors and executive officers of Parent contained
in Schedule I of the Offer to Purchase, which is
incorporated by reference herein.
|
|
|
|
|
Name
|
|
Age
|
|
Position(s)
|
|
Johan Malmquist
|
|
47
|
|
Johan Malmquist joined Purchasers board of directors in
2008. Mr. Malmquist has served on Getinges board of
directors since 1997, has been employed by Getinge since 1990
and has served as President and Chief Executive Officer since
May 1997. He is a citizen of Sweden.
|
Ulf Grunander
|
|
54
|
|
Ulf Grunander joined Purchasers board of directors in
2008. Mr. Grunander has been President of Purchaser since
2008 and has served as Chief Financial Officer of Getinge since
1993. Mr. Grunander is a Swedish citizen.
|
Heribert Ballhaus
|
|
56
|
|
Heribert Ballhaus joined Purchasers board of directors in
2008. Mr. Ballhaus has been Treasurer of Purchaser since 2008
and has served as Getinges Executive Vice President for
Medical Systems since November 2001. Since January 2008, Mr.
Ballhaus has also served as President of Maquet LLC. Mr.
Ballhaus is a German citizen.
|
Michael Rieder
|
|
56
|
|
Michael Rieder joined Purchasers board of directors in
2008. Mr. Rieder has served as Getinges Executive
Vice President Sales & Marketing Medical Systems since
November 2001. Mr. Rieder is a German citizen.
|
Reinhard Mayer
|
|
41
|
|
Reinhard Mayer joined Purchasers board of directors in
2008. Mr. Mayer has served as Getinges Chief Financial
Officer for Medical Systems since October 2002. Mr. Mayer is a
German citizen.
|
Christian Keller
|
|
43
|
|
Christian Keller has been Vice President of Purchaser since
2008. Mr. Keller has been employed by Getinge since November
2001, and he has served as a President of Maquet Cardiopulmonary
AG since December 2005. Mr. Keller also served as the Managing
Director of Medikomp GmbH from May 2000 to December 2004,
President and Chief Executive Officer of Maquet Critical Care AB
from January 2005 to August 2005, and Managing Director of
Medikomp GmbH from September 2005 to November 2005. Mr. Keller
is a German citizen.
|
Christoph Issem
|
|
39
|
|
Christoph Issem has been Secretary of Purchaser since 2008.
Mr. Issem has been employed by Getinge since 2002, and has
served as Chief Financial Officer at Getinge USA Inc., since
2007. From 2002 to 2007, Mr. Issem was employed as a Divisional
Controller for Surgical Workplaces at Maquet GmbH & Co.KG.
Mr. Issem is a German citizen.
|
30
Datascope (NASDAQ:DSCP)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Datascope (NASDAQ:DSCP)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024